<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Archivum Immunologiae et Therapiae Experimentalis via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Archivum Immunologiae et Therapiae Experimentalis' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Archivum+Immunologiae+et+Therapiae+Experimentalis&t=Archivum+Immunologiae+et+Therapiae+Experimentalis&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 06:42:45 +0100</lastBuildDate>
        <item>
            <title>Microvesicles in Health and Disease</title>
            <link>http://www.medworm.com/index.php?rid=5666439&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fepj75321728010mh%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Microvesicles (or MVs) are plasma membrane-derived vesicles released from most eukaryotic cells constitutively during early
 apoptosis or at higher levels after chemical or physical stress conditions. This review looks at some of the functions of
 MVs in terms of intercellular communication and ensuant signal transduction, including the transport of proteins (unconventional
 protein export) as well as of mRNA and microRNA. MVs also have roles in membrane repair, the removal of misfolded proteins,
 and in the control of apoptosis. We also discuss the role MVs have been shown to have in invasive growth and metastasis as
 well as in hypoxia in tumours and cerebral ischaemia. The association of MVs in infectious and autoimmune disease is also
 summarised together with their...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666439</comments>
            <pubDate>Fri, 03 Feb 2012 17:10:48 +0100</pubDate>
            <guid isPermaLink="false">5666439</guid>        </item>
        <item>
            <title>Talin, Vinculin and Nestin Expression in Orofacial Muscles of Dystrophin Deficient mdx Mice</title>
            <link>http://www.medworm.com/index.php?rid=5666438&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn651x12k28w7027v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The activity of cytoskeletal proteins like talin, vinculin and nestin increases in muscle that regenerates. Little is known
 about their role or at least their expression in the process of regeneration in masticatory muscles of mdx mice, a model of
 Duchenne muscular dystrophy. To determine a potential role of cytoskeletal proteins in the regeneration process of mdx masticatory
 muscles, we examined the expression of talin 1, talin 2, vinculin and nestin in 100-day-old control and mdx mice using quantitative
 RT-PCR, Western blot analyses and histochemistry. The protein expression of talin 1, talin 2, nestin and vinculin in mdx muscles
 remained unchanged as compared with normal mice. However, in mdx masseter it was found a relative increase of nestin compared
 to contr...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666438</comments>
            <pubDate>Fri, 03 Feb 2012 17:10:48 +0100</pubDate>
            <guid isPermaLink="false">5666438</guid>        </item>
        <item>
            <title>Antibodies in the Treatment of Aplastic Anemia</title>
            <link>http://www.medworm.com/index.php?rid=5666440&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvq837716144575g4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Antibodies have been the cornerstone of treatment of acquired aplastic anemia for more than 25&amp;nbsp;years. Treatment with antithymocyte
 globulin (ATG) is considered pivotal and the addition of cyclosporine improves the overall response rate. This antibody is
 heterogeneous and horse ATG is apparently more effective than rabbit ATG. Several issues remain unsolved in relation to the
 combination of ATG and cyclosporine: cost, toxicity and late clonal disorders. In recent years, alternative immunosuppressive
 therapy has been proposed and new antibodies have emerged: porcine ATG, alemtuzumab, daclizumab, and rituximab. Experience
 with these antibodies is limited to a few studies with alemtuzumab being the most promising, but the results are interesting
 and provocative. ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666440</comments>
            <pubDate>Fri, 03 Feb 2012 17:10:31 +0100</pubDate>
            <guid isPermaLink="false">5666440</guid>        </item>
        <item>
            <title>Sepsis Immunopathology: Perspectives of Monitoring and Modulation of the Immune Disturbances</title>
            <link>http://www.medworm.com/index.php?rid=5666441&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8w21p273g1p4m844%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Septic syndromes are the main cause of death in the intensive care units and although the mortality rates is slowly decreasing,
 the occurrence of the disease has been increasing. The pathogenesis of sepsis includes countless disturbances of the host
 immune system starting with a harmful, infection-triggered exaggerated inflammatory cascade, followed by the development of
 an immunoparalysis state. The latter contributes to the failure in pathogen eradication and leads to secondary infections,
 which are often the cause of fatal complications. In this review, we consider different novel therapeutic strategies for restoration
 of immune function. The use of glucocorticoids, intravenous immunoglobulins, heparin, recombinant human activated protein
 C, granulocyte macroph...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666441</comments>
            <pubDate>Thu, 02 Feb 2012 18:11:05 +0100</pubDate>
            <guid isPermaLink="false">5666441</guid>        </item>
        <item>
            <title>XII European Symposium on Platelet and Granulocyte Immunobiology</title>
            <link>http://www.medworm.com/index.php?rid=5596680&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fptk72183u094p282%2F</link>
            <description>Content Type Journal ArticleCategory AnnouncementPages 79-79DOI 10.1007/s00005-011-0160-z

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-4917Print ISSN 0004-069X
	
		Journal Volume Volume 60
	
		Journal Issue Volume 60, Number 1 (Source: Archivum Immunologiae et Therapiae Experimentalis)</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5596680</comments>
            <pubDate>Wed, 11 Jan 2012 17:47:00 +0100</pubDate>
            <guid isPermaLink="false">5596680</guid>        </item>
        <item>
            <title>Lysophosphatidylcholines: Bioactive Lipids Generated During Storage of Blood Components</title>
            <link>http://www.medworm.com/index.php?rid=5514902&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe317x412864rm282%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Transfusion-related acute lung injury (TRALI) is suggested to be a “two hit” event, resulting from priming and activation
 of pulmonary neutrophils. It is known that neutrophil activation may result from infusion of lysophosphatidylcholines (LysoPCs)
 accumulated during storage of blood components. The aim of our study was to verify whether the LysoPCs are released into the
 storage medium of blood components. We measured the LysoPCs concentration in the supernatants from stored apheresis platelet
 concentrates (PLTs), packed non-leukoreduced red blood cell concentrates (RBCs), leukoreduced red blood cell concentrates
 (L-RBCs), fresh frozen plasma (FFP) and donor plasma (control). Lipids were separated on high-performance thin-layer chromatography,
 detected by pri...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5514902</comments>
            <pubDate>Tue, 13 Dec 2011 17:05:09 +0100</pubDate>
            <guid isPermaLink="false">5514902</guid>        </item>
        <item>
            <title>Acetylcholine Receptor-Induced Experimental Myasthenia Gravis: What Have We Learned from Animal Models After Three Decades?</title>
            <link>http://www.medworm.com/index.php?rid=5486164&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr25n33lu7j3651j3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Myasthenia gravis (MG) is an autoimmune disease caused by an immunological response against the acetylcholine receptor (AChR)
 at the neuromuscular junction. Anti-AChR antibodies induce degradation of the receptor, activation of complement cascade and
 destruction of the post-synaptic membrane, resulting in a functional reduction of AChR availability. The pathophysiological
 role of autoantibodies (auto-Abs) and T helper lymphocytes has been studied in the experimental autoimmune MG (EAMG) models.
 EAMG models have been employed to investigate the factors involved in the development of MG and to suggest new therapies aimed
 to preventing or modulating the ongoing disease. EAMG can be induced in susceptible mouse and rat strains, which develop clinical
 symptoms such as ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486164</comments>
            <pubDate>Wed, 07 Dec 2011 10:56:32 +0100</pubDate>
            <guid isPermaLink="false">5486164</guid>        </item>
        <item>
            <title>Neutrophil Function and Apoptosis in Patients with Chronic Hepatitis C Treated with Pegylated Interferon α and Ribavirin</title>
            <link>http://www.medworm.com/index.php?rid=5486165&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg0um531275j14g10%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The role of neutrophils in the pathogenesis of chronic hepatitis C as well as the effect of pegylated interferon α (PEG-IFN-α)
 and ribavirin treatment on neutrophil function is not precisely known. The study included 32 patients with CCH aged between
 19 and 58&amp;nbsp;years (mean 33.5&amp;nbsp;years). Before and after 12&amp;nbsp;weeks of treatment with Peg-IFN-α and ribavirin, intracellular reactive
 oxygen species (ROS) level, expression of adhesion molecules CD11b/MAC-1, CD16, CD18 and CD62L on neutrophils, as well as
 apoptosis and necrosis of these cells were analyzed with the use of flow cytometry. During antiviral therapy, a statistically
 significant decrease of mean fluorescence intensity for CD16 high and CD62 and increase for CD11b/MAC-1 along with the increased
 a...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486165</comments>
            <pubDate>Wed, 07 Dec 2011 10:56:30 +0100</pubDate>
            <guid isPermaLink="false">5486165</guid>        </item>
        <item>
            <title>Immune Regulation by Sphingosine 1-Phosphate and Its Receptors</title>
            <link>http://www.medworm.com/index.php?rid=5486166&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe80l21n2k31j8607%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It is well established that the lysophospholipid and signalling molecule sphingosine 1-phosphate (S1P) has many important
 functions in immune surveillance. S1P is produced from sphingosine by two distinct sphingosine kinases, SphK1 and SphK2, and
 acts as an intracellular messenger and as an extracellular ligand of five G protein-coupled cell surface receptors designated
 S1P1–S1P5. S1P not only regulates peripheral lymphocyte circulation, but also influences their differentiation, activation, infiltration,
 and local positioning. The therapeutic value of modulating S1P metabolism and S1P receptor function is currently tested in
 clinical trials and holds great promise for treatment of different autoimmune diseases. Despite its obvious contribution to
 immune regulat...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486166</comments>
            <pubDate>Wed, 07 Dec 2011 10:52:31 +0100</pubDate>
            <guid isPermaLink="false">5486166</guid>        </item>
        <item>
            <title>Immunotherapy of Lung Adenocarcinoma Patient with Peptide-Pulsed Dendritic Cells: a Case Report</title>
            <link>http://www.medworm.com/index.php?rid=5486167&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft67v1k86806114r7%2F</link>
            <description>We described the effect of peptide-loaded DCs-based immunotherapy on patient with recurrent surgically
 resected adenocarcinoma with bronchoalveolar feature with co-existing of Takayasu arteritis and chronic hepatitis B. In January
 2010, 61-year-old patient received subcutaneously four bi-weekly vaccinations of DCs loaded with MUC1 and MAGE-3 epitopes.
 Additionally, he received three bi-weekly booster vaccinations after 7&amp;nbsp;months from the first course of immunotherapy. Delayed-type
 hypersensitivity test was positive only for MAGE-3 antigen. The evidence expansion of MAGE-3-specific CD8+ cells after first vaccination and after third vaccination during boosters injections was observed (from 0.08% before vaccination
 to 0.5% after first vaccination; from 0.05% before booster vaccinatio...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486167</comments>
            <pubDate>Mon, 05 Dec 2011 17:42:17 +0100</pubDate>
            <guid isPermaLink="false">5486167</guid>        </item>
        <item>
            <title>Neutrophil Myeloperoxidase: Soldier and Statesman</title>
            <link>http://www.medworm.com/index.php?rid=5486168&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F27173336315v38n7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Myeloperoxidase (MPO) is a major protein constituent of the primary granules of vertebrate neutrophils. It catalyses the hydrogen
 peroxide-mediated oxidation of halide ions to hypohalous acids, especially HOCl. These reactive oxygen species can participate
 in a variety of secondary reactions, leading to modifications of amino acids and many types of biological macromolecules.
 The classic paradigm views MPO as a component of the phagocyte oxygen-dependent intracellular microbicidal system, and thus
 an important arm of the effector phase of innate immune responses. However, the limited immunodeficiency associated with lack
 of MPO in mouse and human models has challenged this paradigm. In this review we examine more recent information on the interaction
 between MPO, ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486168</comments>
            <pubDate>Mon, 05 Dec 2011 17:42:16 +0100</pubDate>
            <guid isPermaLink="false">5486168</guid>        </item>
        <item>
            <title>Molecular Mechanisms and Pathological Consequences of Endotoxin Tolerance and Priming</title>
            <link>http://www.medworm.com/index.php?rid=5486169&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh03v347m85522181%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Lipopolysaccharide (LPS), a component of Gram-negative bacteria, is a potent inflammatory stimulant, with high doses due to
 disseminated bacterial infection resulting in systemic inflammatory response syndrome and death. Lower doses can induce a
 state of tolerance to subsequent toxic doses of LPS, but extremely low doses have an opposite effect, priming the immune system
 for an even more violent response to subsequent challenge. A substantial body of research exists on the phenomenon of endotoxin
 tolerance, which appears to be a state of generalized dampening of inflammatory pathways. Comparatively little is known about
 the mechanisms or indeed the phenomenon of priming, particularly regarding the shift from a priming to a tolerizing response.
 Our aim is to review...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486169</comments>
            <pubDate>Mon, 05 Dec 2011 17:42:15 +0100</pubDate>
            <guid isPermaLink="false">5486169</guid>        </item>
        <item>
            <title>Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: Current Status</title>
            <link>http://www.medworm.com/index.php?rid=5486171&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F87n52t36kn834301%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hematopoietic cell transplantation (HCT) offers potentially curative therapy for patients with myelodysplastic syndrome (MDS).
 However, as the majority of patients with MDS is in the 7th or 8th decade of life, only few of these patients were transplanted
 following high-dose conditioning regimens. The development of reduced-intensity conditioning has allowed to apply HCT also
 to older patients and those with clinically relevant comorbid conditions. Dependent upon disease status and the type of clonal
 chromosomal abnormalities present at the time of HCT, some 25–75% of patients will be cured of their disease and survive long
 term. Recent results with HLA-matched unrelated donors are comparable to those with HLA genotypically identical siblings.
 The increasing use ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486171</comments>
            <pubDate>Mon, 05 Dec 2011 17:42:13 +0100</pubDate>
            <guid isPermaLink="false">5486171</guid>        </item>
        <item>
            <title>Archivum Immunologiae et Therapiae Experimentalis in Its 60th Year of Publication (1953–2012)</title>
            <link>http://www.medworm.com/index.php?rid=5486170&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg54855h5gw53rn47%2F</link>
            <description>Content Type Journal ArticleCategory IntroductionPages 1-1DOI 10.1007/s00005-011-0151-0

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-4917Print ISSN 0004-069X (Source: Archivum Immunologiae et Therapiae Experimentalis)</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486170</comments>
            <pubDate>Mon, 05 Dec 2011 17:42:13 +0100</pubDate>
            <guid isPermaLink="false">5486170</guid>        </item>
        <item>
            <title>Islet Transplantation: Factors in Short-Term Islet Survival</title>
            <link>http://www.medworm.com/index.php?rid=5303805&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb380576450102n07%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Islet transplantation has the potential to cure type 1 diabetes. In recent years, the proportion of patients achieving initial
 insulin independence has improved, but longer term outcomes remain poor compared to those for whole pancreas transplants.
 This review article will discuss factors affecting islet yield and viability leading up to transplantation and in the immediate
 post-transplant period.
 
 
	Content Type Journal ArticleCategory ReviewPages 1-9DOI 10.1007/s00005-011-0143-0Authors
		Natasha A. Deters, Diabetes and Transcription Factors, Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW 2010, AustraliaRebecca A. Stokes, Diabetes and Transcription Factors, Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW 2010, Aus...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5303805</comments>
            <pubDate>Fri, 07 Oct 2011 15:59:06 +0100</pubDate>
            <guid isPermaLink="false">5303805</guid>        </item>
        <item>
            <title>Oxidative and Nitrosative Stress on Phagocytes’ Function: from Effective Defense to Immunity Evasion Mechanisms</title>
            <link>http://www.medworm.com/index.php?rid=5296299&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa1866q416607n523%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although oxygen, nitrogen, and chlorine reactive species have been associated with disease pathogenesis, their partial absence
 is very harmful to the body’s innate immune defense. Lacking of adequate release of free radicals from activated phagocytes
 is related to impaired ability on fungi, bacteria, and protozoa killing. We constructed an updated conceptual landmark regarding
 the paramount role of free radicals in phagocyte defense systems (phagocyte oxidase, myeloperoxidase, and nitric oxide/peroxynitrite
 system) on natural immunity. Diverse fungal, bacterial and protozoal pathogens evade the phagocytes’ oxidative/nitrosative
 burst though antioxidant genes, enzymes and proteins. The most important evasion mechanisms were also described and discussed.
 These i...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5296299</comments>
            <pubDate>Wed, 05 Oct 2011 05:44:36 +0100</pubDate>
            <guid isPermaLink="false">5296299</guid>        </item>
        <item>
            <title>The Transcription Factor PU.1 is a Critical Regulator of Cellular Communication in the Immune System</title>
            <link>http://www.medworm.com/index.php?rid=5296298&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj50n1t66530k7k38%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;PU.1 is an E26 transformation-specific family transcription factor that is required for development of the immune system.
 PU.1 functions at both early and late stages of lymphoid and myeloid differentiation. At least 110 direct target genes of
 PU.1 have been identified since its discovery in 1988. We used the published literature to determine if aspects of PU.1 function
 can be inferred from the identity of target genes that are directly activated. This analysis revealed that 61% of described
 PU.1 target genes encode extracellular proteins or transmembrane proteins, most of which are involved in cellular communication.
 The genes activated by PU.1 can be grouped into pathways based on function. Specific examples of cellular communication pathways
 regulated by PU.1 i...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5296298</comments>
            <pubDate>Wed, 05 Oct 2011 05:44:36 +0100</pubDate>
            <guid isPermaLink="false">5296298</guid>        </item>
        <item>
            <title>NK Cells Prevalence, Subsets and Function in Viral Hepatitis C</title>
            <link>http://www.medworm.com/index.php?rid=5296300&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr0121u9170q7r351%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Innate immunity appears to play an important role in the pathogenesis of viral hepatitis C. Among various cell subsets of
 this immunity natural killer (NK) cells raised particular interest. These cells are abundant in liver, possess significant
 cytotoxic potential and show links with adaptive immunity. They play important role, particularly in the acute phase of viral
 infections, including hepatitis C. They exhibit various types of receptors, either inhibitory or activating, that are able
 to react with distinct ligands on infected cells. Homozygosity of some receptors, namely KIR2DL3 reacting with recipient HLA-C1
 antigens is a herald of good prognosis in hepatitis C virus (HCV) infection. In the early stage of the latter, both the prevalence
 and the cytotoxicity ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5296300</comments>
            <pubDate>Wed, 05 Oct 2011 05:44:35 +0100</pubDate>
            <guid isPermaLink="false">5296300</guid>        </item>
        <item>
            <title>Beclin 1 is Involved in Regulation of Apoptosis and Autophagy During Replication of Ectromelia Virus in Permissive L929 Cells</title>
            <link>http://www.medworm.com/index.php?rid=5296301&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg61482mj303q844q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Several reports have brought to light new and interesting findings on the involvement of autophagy and apoptosis in pathogenesis
 of viral and bacterial diseases, as well as presentation of foreign antigens. Our model studies focused on the involvement
 of apoptosis during replication of highly virulent Moscow strain of ectromelia virus (ECTV-MOS). Here, we show evidence that
 autophagy is induced during mousepox replication in a cell line. Fluorescence microscopy revealed increase of LC3 (microtubule-associated
 protein 1 light chain 3) aggregation in infected as opposed to non-infected control L929 cells. Furthermore, Western blot
 analysis showed that replication of ECTV-MOS in L929 cells led to the increase in LC3-II (marker of autophagic activity) expression.
 Becl...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5296301</comments>
            <pubDate>Wed, 05 Oct 2011 05:44:33 +0100</pubDate>
            <guid isPermaLink="false">5296301</guid>        </item>
        <item>
            <title>Angiogenesis in Oral Lichen Planus: An In Vivo and Immunohistological Evaluation</title>
            <link>http://www.medworm.com/index.php?rid=5284694&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F065003q62p7lxj61%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Oral lichen planus (OLP) is an autoimmune disease with an inflammatory pathogenesis. The angiogenetic phenomenon is a mechanism
 at the base of the pathogenesis of chronic inflammatory processes. The aim of this research is to evaluate the angiogenetic
 phenomenon, comparing an in vitro method with an in vivo one. Thirty OLP patients and 30 healthy subjects were enrolled in
 the study. Immunohistochemical analysis of the vascular-endothelial growth factor (VEGF) and vascular-endothelial adhesion
 molecules were carried out by the means of primary antibodies and anti-CD34, anti-VEGF, anti-CD106 antigen (VCAM-1) and anti-CD54
 antigen (ICAM-1). Capillary density and others capillaroscopic parameters were tested in vivo using oral videocapillaroscopy.
 The results reveal t...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284694</comments>
            <pubDate>Sat, 01 Oct 2011 06:45:55 +0100</pubDate>
            <guid isPermaLink="false">5284694</guid>        </item>
        <item>
            <title>Disseminated Adenovirus Disease in Immunocompromised Patient Successfully Treated with Oral Ribavirin: A Case Report</title>
            <link>http://www.medworm.com/index.php?rid=5284695&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyh67711g6060222q%2F</link>
            <description>This report describes the detection
 and treatment of human adenovirus (HAdVs) disseminated disease in the case of a 46-year-old immunocompromised female having
 myelodysplastic syndrome with refractory cytopenia with multilineage dysplasia: International Prognostic Scoring System 1.
 Serum and urine samples were tested for the presence of adenoviral DNA using the quantitative real-time polymerase chain reaction
 (PCR) assay. For additional confirmation, sequencing of PCR products was also performed. With real-time PCR, we detected HAdV
 DNA in both serum and urine samples. The viral level constantly decreased with applied oral ribavirin therapy. As the result
 of sequencing, HAdVs type 11 was determined. Surveillance of adenovirus by real-time PCR is useful in detecting and monitoring
 di...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284695</comments>
            <pubDate>Sat, 01 Oct 2011 06:45:54 +0100</pubDate>
            <guid isPermaLink="false">5284695</guid>        </item>
        <item>
            <title>Complement in Cancer and Cancer Immunotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5284696&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa1214765g2m21l48%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recently, there has been an increase of interest in the use of biological or immune-based therapies for patients with malignancies.
 This has been informed by the deeper understanding of the crosstalk between the host immune system and malignant tumours,
 as well as the potential advantages of immunotherapy—high specificity and less toxicity compared to standard approaches. The
 particular emphasis of this article is on the role of the complement system in tumour growth and antibody-based cancer immunotherapy.
 The functional consequences from overexpression of complement regulators by tumours and the development of strategies for
 overcoming this are discussed in detail. This review discusses these issues with a view to inspiring the development of new
 agents that c...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284696</comments>
            <pubDate>Fri, 30 Sep 2011 06:31:57 +0100</pubDate>
            <guid isPermaLink="false">5284696</guid>        </item>
        <item>
            <title>Abstracts</title>
            <link>http://www.medworm.com/index.php?rid=5160590&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F75417652gv22j867%2F</link>
            <description>Content Type Journal ArticleCategory AbstractsPages 1-4DOI 10.1007/s00005-011-0141-2

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-4917Print ISSN 0004-069X (Source: Archivum Immunologiae et Therapiae Experimentalis)</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5160590</comments>
            <pubDate>Wed, 24 Aug 2011 16:03:50 +0100</pubDate>
            <guid isPermaLink="false">5160590</guid>        </item>
        <item>
            <title>Proceedings of the Conference “Lymphocyte Development, Tolerance and Autoimmunity: Solved and Open Questions”, Held at the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, on May 12, 2011 (Wrocław, Poland)</title>
            <link>http://www.medworm.com/index.php?rid=5131380&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F615k733k16517887%2F</link>
            <description>Content Type Journal ArticlePages 1-4DOI 10.1007/s00005-011-0142-1Authors
		Pawel Kisielow, Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114 Wrocław, Poland
	

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-4917Print ISSN 0004-069X (Source: Archivum Immunologiae et Therapiae Experimentalis)</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5131380</comments>
            <pubDate>Sat, 13 Aug 2011 06:07:12 +0100</pubDate>
            <guid isPermaLink="false">5131380</guid>        </item>
        <item>
            <title>Apoptosis in Lymphocytes of Pancreatic Cancer Patients: Influence of Preoperative Enteral Immunonutrition and Extensive Surgery</title>
            <link>http://www.medworm.com/index.php?rid=5108700&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr474u441v6561120%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The mechanisms of correcting immune disorders in patients with pancreatic cancer requiring major surgery procedures by introducing
 perioperative immune-enhancing diet (immunonutrition) are still unclear. The purpose of our study was to investigate the effect
 of pancreatic cancer, extensive surgery and immunonutrition versus enteral standard nutrition on the apoptotic signaling pathways.
 The randomized studies were performed in 72 patients before and after pancreatic cancer resection with preoperative standard
 (Group I) or enteral immunonutrition (Group II). The expressions of Bcl-2, Bax, caspases-3, -9, NF-κB, PARP-1/89&amp;nbsp;kDa, TNFR1/CD120a
 and Fas/CD95 in peripheral blood lymphocytes were assessed by western blot analysis and flow cytometry before and on day 1,...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5108700</comments>
            <pubDate>Fri, 05 Aug 2011 05:53:31 +0100</pubDate>
            <guid isPermaLink="false">5108700</guid>        </item>
        <item>
            <title>Expression of Th1/Th2/Th3/Th17-Related Genes in Recurrent Aphthous Ulcers</title>
            <link>http://www.medworm.com/index.php?rid=5086751&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc687162524534418%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The pathogenesis of recurrent aphthous ulceration (RAU) is unknown, although an abnormal immune reaction appears to be involved.
 RAU may result from oral epithelium damage caused by T cell-mediated immune response. To improve understanding of the role
 of T cells in RAU, the present study analyzed. the expression of T cell-related genes in oral ulcers from patients with RAU,
 as well as in healthy non-keratinized oral mucosa from aphthae-free volunteers. Biopsies from RAU patients and healthy individuals
 were analyzed using Human Th1-Th2-Th3 RT2 Profiler PCR Array and qRT-PCR that allowed to quantify the transcript levels of 86 genes related to T cell activation. We
 found that cells present in aphthous ulcers express a characteristic Th1-like gene profile. The majori...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5086751</comments>
            <pubDate>Fri, 29 Jul 2011 16:06:53 +0100</pubDate>
            <guid isPermaLink="false">5086751</guid>        </item>
        <item>
            <title>Clinical Significance of the HLA-E and CD94/NKG2 Interaction</title>
            <link>http://www.medworm.com/index.php?rid=5086752&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy7m68n7052838357%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;HLA-E belongs to the non-classical HLA (class Ib family) broadly defined by a limited polymorphism and a restricted pattern
 of cellular expression. So far, only two functional alleles differing at only one amino acid position (non-synonymous mutation)
 in the α2 heavy chain domain, where an arginine in position 107 in HLA-E*0101 is replaced by a glycine in HLA-E*0103, have
 been reported. The interaction between non-classical HLA-E molecule and CD94/NKG2A receptor plays a crucial role in the immunological
 response involving natural killer (NK) cells and cytotoxic T lymphocytes. All proteins forming CD94/NKG2 receptors are encoded
 by genes situated in the same cluster on chromosome 12, allowing tight control over the order of their expression. The inhibitory
 members...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5086752</comments>
            <pubDate>Thu, 28 Jul 2011 15:56:20 +0100</pubDate>
            <guid isPermaLink="false">5086752</guid>        </item>
        <item>
            <title>Bone Marrow Mesenchymal Cells: How Do They Contribute to Tissue Repair and Are They Really Stem Cells?</title>
            <link>http://www.medworm.com/index.php?rid=5086756&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn85756664k51w182%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Adult stem cells typically generate the cell types of the tissue in which they reside, and thus the range of their differentiation
 is considered limited. Bone marrow mesenchymal stem cells (MSCs) are different from other somatic stem cells in that they
 differentiate not only into the same mesodermal-lineage such as bone, cartilage, and adipocytes but also into other lineages
 of ectodermal and endodermal cells. Thus, MSCs are a unique type of adult stem cells. In addition, MSCs home to damaged sites,
 differentiate into cells specific to the tissue and contribute to tissue repair. Therefore, application of MSCs in the treatment
 of various diseases, including liver dysfunction, myocardial infarction, and central nervous system repair, has been initiated.
 Because MSCs...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5086756</comments>
            <pubDate>Tue, 26 Jul 2011 05:48:59 +0100</pubDate>
            <guid isPermaLink="false">5086756</guid>        </item>
        <item>
            <title>Transitional B Cells: How Well Are the Checkpoints for Specificity Understood?</title>
            <link>http://www.medworm.com/index.php?rid=5086754&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx372800455853313%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It is crucial for the immune system to minimise the number of circulating mature self-reactive B cells, in order to reduce
 the potential for the development of autoantibody-related autoimmune diseases. Studies of animal models have identified two
 major checkpoints that ensure that such cells do not contribute to the naïve B cell repertoire. The first is in the bone marrow
 as B cells develop and the second is in the spleen; B cells that are released from the bone marrow as transitional B cells
 go through more stringent selection in the spleen before they develop into mature naïve B cells. Transitional B cells and
 their maturation have mostly been studied in mice. However, recent studies characterised human transitional B cells and found
 considerable differences t...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5086754</comments>
            <pubDate>Tue, 26 Jul 2011 05:48:59 +0100</pubDate>
            <guid isPermaLink="false">5086754</guid>        </item>
        <item>
            <title>Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs</title>
            <link>http://www.medworm.com/index.php?rid=5069456&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvrrm104n6882r57g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Rel/NF-κB transcription factors play a key role in modulating the response of immunoregulatory genes including cytokines and
 chemokines, cell adhesion molecules, acute phase proteins, and anti-microbial peptides. Furthermore, an array of genes important
 for angiogenesis, tumor invasion and metastasis is also regulated by nuclear factor-κB (NF-κB). Close association of NF-κB
 with inflammation and tumorigenesis makes it an attractive target for basic research as well as for pharmaceutical industries.
 Studies involving various animal and cellular models have revealed the importance of NF-κB in pathobiology of lung diseases.
 This review (a) describes structures, activities, and regulation of NF-κB family members; (b) provides information which implicates
 NF-κB ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5069456</comments>
            <pubDate>Mon, 25 Jul 2011 05:33:55 +0100</pubDate>
            <guid isPermaLink="false">5069456</guid>        </item>
        <item>
            <title>Cancer Vaccines. Any Future?</title>
            <link>http://www.medworm.com/index.php?rid=4935763&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa18480313g106644%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The idea that vaccination can be used to fight cancer is not new. Approximately 100&amp;nbsp;years ago, researchers attempted to stimulate
 a tumor-specific, therapeutic immune response to tumors by injecting patients with cells and extracts from their own tumors,
 or tumors of the same type from different individuals. During the last decade, great efforts have been made to develop immunotherapeutic
 approaches for the treatment of malignant diseases as alternatives to traditional chemo- and radiotherapy. A quintessential
 goal of immunotherapy in cancer is treatment with vaccines that elicit potent anti-tumor immune responses without side effects.
 In this article, we have attempted to review some of the most problematic issues facing the development of cancer vaccines.
 W...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4935763</comments>
            <pubDate>Sun, 05 Jun 2011 05:44:38 +0100</pubDate>
            <guid isPermaLink="false">4935763</guid>        </item>
        <item>
            <title>Recent Progress of Shiga Toxin Neutralizer for Treatment of Infections by Shiga Toxin-Producing Escherichia coli</title>
            <link>http://www.medworm.com/index.php?rid=4935764&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr836x187n8h0pm12%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Infection with Shiga toxin (Stx)-producing Escherichia coli (STEC), including O157:H7, causes bloody diarrhea and hemorrhagic colitis in humans, occasionally resulting in fatal systemic
 complications, such as neurological damage and hemolytic-uremic syndrome. Because Stx is a major virulence factor of the infectious
 disease, a series of Shiga toxin neutralizers with various structural characteristics has been developed as promising therapeutic
 agents. Most of these agents function to bind to the toxin directly and inhibit the binding to its receptor present on the
 target cells. Other neutralizers do not inhibit receptor binding but induce aberrant intracellular transport of the toxin,
 resulting in effective detoxification. Such a novel type of Stx neutralizer provi...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4935764</comments>
            <pubDate>Sun, 05 Jun 2011 05:44:37 +0100</pubDate>
            <guid isPermaLink="false">4935764</guid>        </item>
        <item>
            <title>Prevention of Lyme Disease: Promising Research or Sisyphean Task?</title>
            <link>http://www.medworm.com/index.php?rid=4903351&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm31255r854380148%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 Borrelia burgdorferi sensu lato (Spirochaetes) is a group of at least 12 closely related species, some of which are responsible for chronic zoonotic infection that may
 cause Lyme disease. The only experimentally confirmed vector transmitting Borrelia to mammals is the Ixodes ticks. Borrelia is a highly adapted pathogen that can survive in the host organism in spite of the intense immune responses. Some patients
 have chronic long-lasting complications despite antibiotic therapy, probably due to adverse effects of the immune responses.
 A preventive vaccine against this bacterium has not been available due to the relatively broad spectrum and antigenic variability
 of Borrelia-surface lipoproteins and the different epitope recognition by experimental animals and human...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4903351</comments>
            <pubDate>Thu, 02 Jun 2011 06:06:22 +0100</pubDate>
            <guid isPermaLink="false">4903351</guid>        </item>
        <item>
            <title>Increased Frequency of CD4+CD25highFoxP3+ Regulatory T Cells in Patients with Hepatocellular Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=4903353&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcu0m219v8h21g554%2F</link>
            <description>This study identified an increased frequency of CD4+CD25highFoxP3+ Tregs in patients with HCC. The elevated serum IL-10, TGF-β1 levels also correlated with impaired antitumor responses in
 these patients. Further effort is needed to establish new immunotherapeutic strategies designed to modulate Tregs to promote
 a competent antitumor response.
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s00005-011-0127-0Authors
		Xi Feng, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Chengdu, Sichuan Province, ChinaBo Li, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Chengdu, Sichuan Province, ChinaHui Ye, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Alley, C...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4903353</comments>
            <pubDate>Thu, 02 Jun 2011 06:06:21 +0100</pubDate>
            <guid isPermaLink="false">4903353</guid>        </item>
        <item>
            <title>Bim: Guardian of Tissue Homeostasis and Critical Regulator of the Immune System, Tumorigenesis and Bone Biology</title>
            <link>http://www.medworm.com/index.php?rid=4903352&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl034p5nn77116621%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;One of the most important roles of apoptosis is the maintenance of tissue homeostasis. Impairment of apoptosis leads to a
 number of pathological conditions. In response to apoptotic signals, various proteins are activated in a pathway and signal-specific
 manner. Recently, the pro-apoptotic molecule Bim has attracted increasing attention as a pivotal regulator of tissue homeostasis.
 The Bim expression level is strictly controlled in both transcriptional and post-transcriptional levels. This control is dependent
 on cell, tissue and apoptotic stimuli. The phenotype of Bim-deficient mice is a systemic lupus erythematosus-like autoimmune
 disease with an abnormal accumulation of hematopoietic cells. Bim is thus a critical regulator of hematopoietic cells and
 immune syst...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4903352</comments>
            <pubDate>Thu, 02 Jun 2011 06:06:21 +0100</pubDate>
            <guid isPermaLink="false">4903352</guid>        </item>
        <item>
            <title>Soluble TNF-α Receptor I Encoded on Plasmid Vector and Its Application in Experimental Gene Therapy of Radiation-Induced Lung Fibrosis</title>
            <link>http://www.medworm.com/index.php?rid=4903354&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu2hh208l58238769%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Post-radiation inflammatory reaction leads to an irreversible pulmonary fibrosis which may cause lethal respiratory insufficiency.
 Pathological inflammatory and fibrotic changes might be attenuated by inhibiting tumour necrosis factor (TNF)-α activity using
 TNF-α soluble receptors. Thus, an experimental antifibrotic gene therapy with the plasmid vector encoding a mouse soluble
 receptor I for TNF-α (psTNFR-I) was assessed. Soluble TNFR-I encoding gene was cloned into pcDNA3.1 plasmid. The ability of
 psTNFR-I expressing vector to transfect cells, and its biological activity in vitro and in vivo were examined by PCR, RT-PCR,
 MTT assay and ELISA. The C57Bl/6J mice received single intramuscular injection of psTNFR-I, conjugated with polyetylenimine
 (PEI) 25&amp;nbsp;kDa...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4903354</comments>
            <pubDate>Thu, 02 Jun 2011 06:06:19 +0100</pubDate>
            <guid isPermaLink="false">4903354</guid>        </item>
        <item>
            <title>Targeting NF-κB and HIF-1 Pathways for the Treatment of Cancer: Part II</title>
            <link>http://www.medworm.com/index.php?rid=4903355&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn74568k64735n867%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hypoxia that originates from disturbed growth of solid tumors initiates a cascade of intracellular events engaging hypoxia-inducible
 factors, HIF-1 and HIF-2. Overexpression of HIF has been confirmed in solid tumors and was unfortunately accompanied with
 chemo- and radioresistance observed in many patients. Multiple cellular pathways resulting in HIF activation could be successfully
 inhibited by use of different kinds of drugs (e.g. topotecan, heat shock protein 90 and mTOR inhibitors, YC-1, pleurotin or
 2-methoxyestradiol), which are being subjected into intensive investigation in clinical trials.
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s00005-011-0132-3Authors
		Jacek Wilczynski, Polish Mother’s Health Center Research Institute, Rzgowska 281/289, 9...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4903355</comments>
            <pubDate>Mon, 30 May 2011 16:43:13 +0100</pubDate>
            <guid isPermaLink="false">4903355</guid>        </item>
        <item>
            <title>Targeting NF-κB and HIF-1 Pathways for the Treatment of Cancer: Part I</title>
            <link>http://www.medworm.com/index.php?rid=4903356&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw6u407r2p2237066%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The process of chronic inflammation is a common link which connects different kinds of environmental pollutants and infections
 with tumorigenesis. Transcription factor NF-κB is a common final target for many inflammatory and cell proliferation pathways,
 independent of the source of stimuli (e.g., cytokines, growth factors, environmental carcinogens, radiation, hypoxia, bacteria,
 and viruses). Over-activation of NF-κB has been confirmed in many tumors, resulting in worse prognosis for patient survival.
 Therefore, inhibition of cellular pathways for NF-κB activation is nowadays considered as a promising anti-cancer therapy
 and is extensively studied in clinical trials, or even has been adopted as an approved therapy in some kinds of cancer.
 
 
	Content Type Journ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4903356</comments>
            <pubDate>Mon, 30 May 2011 16:43:09 +0100</pubDate>
            <guid isPermaLink="false">4903356</guid>        </item>
        <item>
            <title>Phosphatidylserine-Containing Liposomes: Potential Pharmacological Interventions Against Inflammatory and Immune Diseases Through the Production of Prostaglandin E2 After Uptake by Myeloid Derived Phagocytes</title>
            <link>http://www.medworm.com/index.php?rid=4709576&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F35554213664n587j%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Phosphatidylserine (PS), which is normally located on the inner leaflet of the plasma membrane, translocates to the outer
 leaflet at the early stage of apoptosis. The PS externalization provides a signal for phagocytes to initiate uptake of apoptotic
 cells. After phagocytosis of apoptotic cells, phagocytes induce the secretion of anti-inflammatory mediators including prostaglandin
 E2 (PGE2). PS-containing liposomes (PSLs) can mimic the effects of apoptotic cells on phagocytes to induce the secretion of PGE2. PSLs induce the PGE2 secretion from microglia without induction of either cyclooxygenase (COX)-2 or microsomal prostaglandin E synthase (mPGES)-1.
 PSLs are found to rather utilize COX-1/mPGES-2 system to produce PGE2 secretion and then shift microglia and macrop...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4709576</comments>
            <pubDate>Sat, 09 Apr 2011 15:47:58 +0100</pubDate>
            <guid isPermaLink="false">4709576</guid>        </item>
        <item>
            <title>Myelin Restoration: Progress and Prospects for Human Cell Replacement Therapies</title>
            <link>http://www.medworm.com/index.php?rid=4685365&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj230x13318546130%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Oligodendrocytes are the primary source of myelin in the adult central nervous system (CNS), and their dysfunction or loss
 underlies several diseases of both children and adults. Dysmyelinating and demyelinating diseases are thus attractive targets
 for cell-based strategies since replacement of a single presumably homogeneous cell type has the potential to restore functional
 levels of myelin. To understand the obstacles that cell-replacement therapy might face, we review oligodendrocyte biology
 and emphasize aspects of oligodendrocyte development that will need to be recapitulated by exogenously transplanted cells,
 including migration from the site of transplantation, axon recognition, terminal differentiation, axon wrapping, and myelin
 production and maintenance....</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4685365</comments>
            <pubDate>Sat, 02 Apr 2011 05:51:05 +0100</pubDate>
            <guid isPermaLink="false">4685365</guid>        </item>
        <item>
            <title>Glucose Metabolism Disorders and the Risk of Cancer</title>
            <link>http://www.medworm.com/index.php?rid=4664156&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhw20347042hn4134%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diabetes and cancer are diseases which take the size of an epidemic spread across the globe. Those diseases are influenced
 by many factors, both genetic and environmental. Precise knowledge of the complex relationships and interactions between these
 two conditions is of great importance for their prevention and treatment. Many epidemiological studies have shown that certain
 types of cancer, especially gastrointestinal cancers (pancreas, liver, colon) and also the urinary and reproductive system
 cancers in women are more common in patients with diabetes or related metabolic disorders. There are also studies showing
 the inverse relationship between diabetes and cancer, or the lack of it, but they are less numerous and relate mainly to prostate
 cancer or squamous cel...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4664156</comments>
            <pubDate>Tue, 29 Mar 2011 17:36:23 +0100</pubDate>
            <guid isPermaLink="false">4664156</guid>        </item>
        <item>
            <title>Gut Microbiota, Probiotics and Inflammatory Bowel Disease</title>
            <link>http://www.medworm.com/index.php?rid=4664157&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F478242t25p5p2728%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The colonization of humans with commensals is critical for our well-being. This tightly regulated symbiotic relationship depends
 on the flora and an intact mucosal immune system. A disturbance of either compound can cause intestinal inflammation. This
 review summarizes extrinsic and intrinsic factors contributing to intestinal dysbiosis and inflammatory bowel disease.
 
 
	Content Type Journal ArticlePages 1-17DOI 10.1007/s00005-011-0122-5Authors
		Johannes Stephani, Department of Internal Medicine I, Ulm University, Helmholtzstr, 8/1, 89031 Ulm, GermanyKatarina Radulovic, Department of Internal Medicine I, Ulm University, Helmholtzstr, 8/1, 89031 Ulm, GermanyJan Hendrik Niess, Department of Internal Medicine I, Ulm University, Helmholtzstr, 8/1, 89031 Ulm, Germany
	
...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4664157</comments>
            <pubDate>Tue, 29 Mar 2011 07:03:45 +0100</pubDate>
            <guid isPermaLink="false">4664157</guid>        </item>
        <item>
            <title>Ethical Considerations in Face Transplantation: Ethical Issues Related to Inclusion Criteria for Face Transplant Candidates</title>
            <link>http://www.medworm.com/index.php?rid=4653917&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk04812n2x707673u%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s00005-011-0121-6Authors
		Maria Siemionow, Department of Plastic Surgery, Cleveland Clinic, 9500 Euclid Avenue/Desk A-60, Cleveland, OH 44195, USA
	

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-4917Print ISSN 0004-069X (Source: Archivum Immunologiae et Therapiae Experimentalis)</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4653917</comments>
            <pubDate>Sun, 27 Mar 2011 05:55:05 +0100</pubDate>
            <guid isPermaLink="false">4653917</guid>        </item>
        <item>
            <title>The Patterns of MHC Association in Aplastic and Non-aplastic Paroxysmal Nocturnal Hemoglobinuria</title>
            <link>http://www.medworm.com/index.php?rid=4653916&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fct4n26258423p344%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The deficiency of glycosyl-phosphatidylinositol (GPI)-anchored proteins in plasma membranes of PIG-A gene mutated hematopoietic stem cells (HSCs) is so far insufficient to explain the domination of paroxysmal nocturnal hemoglobinuria
 (PNH) clone over the normal HSC. We attempted to elucidate possible link between MHC and initial severe aplastic anemia (ISAA/PNH)
 type and non-aplastic (n/PNH) outcome of PNH. In 50 PNH patients assigned as ISAA/PNH (n&amp;nbsp;=&amp;nbsp;13), n/PNH (n&amp;nbsp;=&amp;nbsp;33) or nonassigned (n&amp;nbsp;=&amp;nbsp;4) and 200 ethnically matched controls we analyzed MHC associations. Our data confirmed strong associations of DRB1*15:01 (RR&amp;nbsp;=&amp;nbsp;3.51, p&amp;nbsp;=&amp;nbsp;0.0011) and DQB1*06:02 (RR&amp;nbsp;=&amp;nbsp;7.09, p&amp;nbsp;=&amp;nbsp;0.000026) alleles, especially with ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4653916</comments>
            <pubDate>Sun, 27 Mar 2011 05:55:05 +0100</pubDate>
            <guid isPermaLink="false">4653916</guid>        </item>
        <item>
            <title>Gender Specific Differences in the Immune Response to Infection</title>
            <link>http://www.medworm.com/index.php?rid=4653918&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg7h1v7n1r124j007%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There are many instances where males and females differ in the susceptibility to infections. The reason for these differences
 in susceptibility is multifactorial. The primary cause is thought to be due to differences induced by sex hormones and their
 effects on gene expression as well as the immune system, but may also be due to innate physiological differences between males
 and females. This review summarizes gender specific differences seen in infections caused by bacteria, fungi, parasites and
 viruses. Ultimately, gender specific differences appear to be dependent on the microbe causing the infection, as not every
 infection with a specific microbial type results in increased susceptibility of one gender over the other. This suggests that
 there is an interaction...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4653918</comments>
            <pubDate>Fri, 25 Mar 2011 18:55:21 +0100</pubDate>
            <guid isPermaLink="false">4653918</guid>        </item>
        <item>
            <title>CXCL8 and CCL5 Expression in Synovial Fluid and Blood Serum in Patients with Osteoarthritis of the Knee</title>
            <link>http://www.medworm.com/index.php?rid=4513027&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh2133m7019524507%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chemokines proved able to induce release of enzymes relevant in cartilage damage. The present study addressed the levels of
 CXCL8 and CCL5 and the potential role of these chemokines in predicting the morphological changes in the course of osteoarthritis
 (OA). Synovial fluid (SF) and blood serum were obtained from 20 patients undergoing knee replacement surgery because of OA.
 For comparison, samples were also obtained from another 20 patients during diagnostic or therapeutic arthroscopy performed
 because of knee injury. The samples were analyzed for CXCL8 and CCL5 using enzyme-linked immunosorbent assay. SF from the
 group with OA showed significantly (p&amp;nbsp;=&amp;nbsp;0.024) increased levels of CXCL8 when compared with the group after knee injury. We have not demonstra...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4513027</comments>
            <pubDate>Sat, 19 Feb 2011 06:55:39 +0100</pubDate>
            <guid isPermaLink="false">4513027</guid>        </item>
        <item>
            <title>Pathogenesis of Joint Destruction in Rheumatoid Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=4495793&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn068412406507116%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Synovial mesenchymal cells, matrix metalloproteinases (MMPs), and osteoclasts are the three major players directly responsible
 for the pathogenesis of rheumatoid joint destruction. First, synovial mesenchymal cells, internally driven by a transcription
 factor c-Fos/AP-1, not only directly invade cartilage and bone as a granulation tissue called “pannus” but also release inflammatory
 cytokine interleukin (IL)-1β. IL-1β induces MMPs and activates osteoclasts. Synovial cells can also present antigen to T cells
 to drive antigen-specific immune responses. Second, cartilaginous joint matrix can only be degraded after the first attack
 of collagen fibrils by MMPs, and importantly, most of the MMPs are under the control of c-Fos/AP-1 and IL-1β as well. Third,
 differ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4495793</comments>
            <pubDate>Wed, 16 Feb 2011 06:59:42 +0100</pubDate>
            <guid isPermaLink="false">4495793</guid>        </item>
        <item>
            <title>The Cystic Fibrosis Neutrophil: A Specialized Yet Potentially Defective Cell</title>
            <link>http://www.medworm.com/index.php?rid=4470874&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F06p621012u524l11%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cystic fibrosis (CF) is one of the commonest genetically inherited diseases in the world. It is characterized by recurrent
 respiratory tract infections eventually leading to respiratory failure. One of the hallmarks of this disease is a persistent
 and predominantly neutrophil driven inflammation. Neutrophils provide the first line of defence by killing and digesting phagocytosed
 bacteria and fungi, yet despite advances in our understanding of the molecular and cellular basis of CF, there remains a paradox
 of why recruited CF neutrophils fail to eradicate bacterial infections in the lung. This review describes mechanisms involved
 in neutrophil migration, microbial killing and apoptosis leading to inflammatory resolution. We discuss dysregulated neutrophil
 activity ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4470874</comments>
            <pubDate>Thu, 10 Feb 2011 19:58:57 +0100</pubDate>
            <guid isPermaLink="false">4470874</guid>        </item>
        <item>
            <title>γδ T cell Receptor Ligands and Modes of Antigen Recognition</title>
            <link>http://www.medworm.com/index.php?rid=4451020&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F23360196858j6027%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;T lymphocytes expressing the γδ-type of T cell receptors (TCRs) for antigens contribute to all aspects of immune responses,
 including defenses against viruses, bacteria, parasites and tumors, allergy and autoimmunity. Multiple subsets have been individualized
 in humans as well as in mice and they appear to recognize in a TCR-dependent manner antigens as diverse as small non-peptidic
 molecules, soluble or membrane-anchored polypeptides and molecules related to MHC antigens on cell surfaces, implying diverse
 modes of antigen recognition. We review here the γδ TCR ligands which have been identified along the years and their characteristics,
 with emphasis on a few systems which have been extensively studied such as human γδ T cells responding to phosphoantigens
 ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4451020</comments>
            <pubDate>Sun, 06 Feb 2011 06:36:43 +0100</pubDate>
            <guid isPermaLink="false">4451020</guid>        </item>
        <item>
            <title>Innate Immunity Signaling Pathways: Links between Immunonutrition and Responses to Sepsis</title>
            <link>http://www.medworm.com/index.php?rid=4451022&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Feq27v97176751880%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Septic infections in patients treated in intensive care units show the highest mortality rates. Despite advances in treatment
 methods, there is still no therapy available to efficiently reduce the excessive inflammatory response, which can increase
 the risk of multiple organ failure. One of the ways to discover new, more efficient treatment methods involves regulating
 the mechanisms of inflammatory response to a massive infection. Toll-like receptors (TLRs) that recognize pathogen-associated
 molecular patterns play a significant role in innate antibacterial and inflammatory responses. The regulatory impact of immunonutrition
 on TLR expression in septic patients seems to be a promising research direction. This paper presents the main mechanisms for
 the innate immun...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4451022</comments>
            <pubDate>Sat, 05 Feb 2011 16:56:32 +0100</pubDate>
            <guid isPermaLink="false">4451022</guid>        </item>
        <item>
            <title>Protein Kinase C Isoforms in Neutrophil Adhesion and Activation</title>
            <link>http://www.medworm.com/index.php?rid=4451021&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn715127643452646%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neutrophils are the first line of defense against bacterial and mycotic pathogens. In order to reach the pathogens, neutrophils
 need to transmigrate through the vascular endothelium and migrate to the site of infection. Defense strategies against pathogens
 include phagocytosis, production and release of oxygen radicals through the oxidative burst, and degranulation of antimicrobial
 and inflammatory molecules. Protein kinase C (PKC)-δ is required for full assembly of NADPH oxidase and activation of the
 respiratory burst. Neutrophils also express PKC-α and -β, which may be involved in adhesion, degranulation and phagocytosis,
 but the evidence is not conclusive yet. This review focuses on the potential impact of protein kinase C isoforms on neutrophil
 adhesion and...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4451021</comments>
            <pubDate>Sat, 05 Feb 2011 16:56:32 +0100</pubDate>
            <guid isPermaLink="false">4451021</guid>        </item>
        <item>
            <title>Physiological Roles of Mammalian Sulfate Transporters NaS1 and Sat1</title>
            <link>http://www.medworm.com/index.php?rid=4451023&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw1637447m2p01233%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;This review summarizes the physiological roles of the renal sulfate transporters NaS1 (Slc13a1) and Sat1 (Slc26a1). NaS1 and
 Sat1 encode renal anion transporters that mediate proximal tubular sulfate reabsorption and thereby regulate blood sulfate
 levels. Targeted disruption of murine NaS1 and Sat1 leads to hyposulfatemia and hypersulfaturia. Sat1 null mice also exhibit
 hyperoxalemia, hyperoxaluria and calcium oxalate urolithiasis. Dysregulation of NaS1 and Sat1 leads to hypersulfaturia, hyposulfatemia and liver damage. Loss of Sat1 leads additionally to hyperoxaluria with hyperoxalemia,
 nephrocalcinosis and calcium oxalate urolithiasis. These data indicate that the renal anion transporters NaS1 and Sat1 are
 essential for sulfate and oxalate homeostasis, respective...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4451023</comments>
            <pubDate>Sat, 05 Feb 2011 16:56:30 +0100</pubDate>
            <guid isPermaLink="false">4451023</guid>        </item>
        <item>
            <title>CD46 Plasticity and Its Inflammatory Bias in Multiple Sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4415183&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm613757108ru6g35%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Known as a link to the adaptive immune system, a complement regulator, a “pathogen magnet” and more recently as an inducer
 of autophagy, CD46 is the human receptor that refuses to be put in a box. This review summarizes the current roles of CD46
 during immune responses and highlights the role of CD46 as both a promoter and attenuator of the immune response. In patients
 with multiple sclerosis (MS), CD46 responses are overwhelmingly pro-inflammatory with notable defects in cytokine and chemokine
 production. Understanding the role of CD46 as an inflammatory regulator is a distant goal considering the darkness in which
 its regulatory mechanisms reside. Further research into the regulation of CD46 expression through its internalization and
 processing will undoubte...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4415183</comments>
            <pubDate>Wed, 26 Jan 2011 19:50:29 +0100</pubDate>
            <guid isPermaLink="false">4415183</guid>        </item>
        <item>
            <title>Serodiagnosis of Borreliosis: Indirect Immunofluorescence Assay, Enzyme-Linked Immunosorbent Assay and Immunoblotting</title>
            <link>http://www.medworm.com/index.php?rid=4400385&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0878mr7470869k03%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Lyme disease is an infectious, multi-system, tick-borne disease caused by genospecies of Borrelia burgdorferi bacteria sensu lato, characterized by remarkable heterogeneity. In this situation choosing an optimal antigen array for diagnostic
 tests seems problematic. The serological tests for borrelia routinely done in laboratories often produce ambiguous results,
 which makes a proper diagnosis rather complicated and thus delays the implementation of an appropriate treatment regimen.
 Thirty-seven outpatients and eight inpatients with suspected borreliosis diagnosis hospitalized at the Clinics of the Pomeranian
 Medical University (Szczecin, Poland), participated in the study. In order to detect the antibodies against Borrelia sensu lato three kinds of serological tests...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4400385</comments>
            <pubDate>Sat, 22 Jan 2011 07:06:29 +0100</pubDate>
            <guid isPermaLink="false">4400385</guid>        </item>
        <item>
            <title>Relapse of Acute Lymphoblastic Leukemia in Children in the Context of Microarray Analyses</title>
            <link>http://www.medworm.com/index.php?rid=4383272&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm355787w26512555%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Over the last four decades the treatment of patients with newly diagnosed childhood acute lymphoblastic leukemia (ALL) has
 improved remarkably. However, still about 20% of children with ALL relapse despite risk-adapted polychemotherapy. The prognosis
 of relapsed ALL is relatively poor, even with modern aggressive chemotherapy. Identification of the biological and genetic
 mechanisms contributing to recurrence in patients with ALL is critical for the development of effective therapeutic strategies
 to treat refractory leukemic patients. Allogeneic hematopoietic stem-cell transplantation is the treatment of choice for many
 children with relapsed ALL. The gene expression profile obtained by microarray technology could provide important determinants
 of the drug response...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4383272</comments>
            <pubDate>Tue, 18 Jan 2011 19:37:58 +0100</pubDate>
            <guid isPermaLink="false">4383272</guid>        </item>
        <item>
            <title>Dual Peripheral Actions of Immune Cells in Neuropathic Pain</title>
            <link>http://www.medworm.com/index.php?rid=4356078&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl15018736086m14n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ability to perceive physiological pain is essential in protecting the individual from tissue destruction. In contrast, pathological
 chronic pain is an expression of maladaptive alterations outlasting its biological usefulness. In such conditions even eating,
 speaking or wearing clothes might be painful, as in neuropathic pain. Such pain is caused by diseases or injuries affecting
 nerves (e.g. diabetes, trigeminal neuralgia or amputation). Neuropathic pain is not an exclusive neuronal phenomenon but also
 involves immune responses. Damaged peripheral nerves are infiltrated by mast cells, granulocytes, macrophages and T lymphocytes.
 It is widely emphasized that these cells, via secretion of inflammatory mediators (e.g. proinflammatory cytokines, chemokines),
 contribu...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4356078</comments>
            <pubDate>Fri, 14 Jan 2011 14:29:44 +0100</pubDate>
            <guid isPermaLink="false">4356078</guid>        </item>
        <item>
            <title>Legal and Ethical Aspects of Ghostwriting in Medicine</title>
            <link>http://www.medworm.com/index.php?rid=4356077&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv7700nh6k870l222%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ghostwriting in medicine represents a highly significant problem in both legal and ethical terms, and particularly in recent
 years owing to a sudden increase in the practice. The main goal in this paper is to present the legal and ethical rules connected
 with the ghostwriting phenomenon. The problem is presented in the context of international, European and Polish law. From
 a legal perspective the issues bound up with ghostwriting are those of the notion and authorship of a work, authors’ rights
 (both moral rights and copyright), the content of these rights and their nature, as well as the question of the transfer of
 such rights. From the point of view of ethics there arises a need for reflection on honesty, accuracy and credibility as defined
 both generally and...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4356077</comments>
            <pubDate>Fri, 14 Jan 2011 14:29:44 +0100</pubDate>
            <guid isPermaLink="false">4356077</guid>        </item>
        <item>
            <title>Tuning of CD40–CD154 Interactions in Human B-Lymphocyte Activation: A Broad Array of In Vitro Models for a Complex In Vivo Situation</title>
            <link>http://www.medworm.com/index.php?rid=4356079&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fung3266p71nw0774%2F</link>
            <description>The objective
 of this review is to present an overview of the great diversity of CD40 agonists used in in vitro models of B-lymphocyte activation,
 with a particular emphasis on variations in the resulting strength of CD40 signaling generated by these models. A better understanding
 of these models could open up new avenues for the rational use of human B lymphocytes as antigen-presenting cells in cellular
 therapies.
 
 
	Content Type Journal ArticlePages 1-16DOI 10.1007/s00005-010-0108-8Authors
		Sonia Néron, Ingénierie cellulaire, Recherche et développement, Héma-Québec, 1070 avenue des Sciences-de-la-Vie, Québec, QC G1V 5C3, CanadaPhilippe J. Nadeau, Ingénierie cellulaire, Recherche et développement, Héma-Québec, 1070 avenue des Sciences-de-la-Vie, Québec, QC G1V 5C3, Canad...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4356079</comments>
            <pubDate>Fri, 14 Jan 2011 14:29:33 +0100</pubDate>
            <guid isPermaLink="false">4356079</guid>        </item>
        <item>
            <title>Antiviral Signaling Through Retinoic Acid-Inducible Gene-I-Like Receptors</title>
            <link>http://www.medworm.com/index.php?rid=4356080&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk78371r562230638%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The innate immune system is essential for the first line of host defense against micropathogens. In virus-infected cells,
 exposed viral nucleotides are sensed by pattern recognition receptors (PRRs), resulting in the induction of type I interferon.
 Retinoic acid-inducible gene-I-like receptors (RLRs) are a member of PRRs and are known to be crucial molecules in innate
 immune responses. Upon viral recognition, RLRs recruit their specific adaptor molecules, leading to the activation of antiviral
 signaling molecules including interferon regulatory factor-3 and nuclear factor-κB. Mitochondrial antiviral signaling (MAVS)
 protein is also known as one of the adaptor molecules responsible for antiviral signaling triggered by RLRs. Recent reports
 have identified numerous ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4356080</comments>
            <pubDate>Fri, 14 Jan 2011 14:29:27 +0100</pubDate>
            <guid isPermaLink="false">4356080</guid>        </item>
        <item>
            <title>How do Tumors Actively Escape from Host Immunosurveillance?</title>
            <link>http://www.medworm.com/index.php?rid=4046272&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd802364w75043t0x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The immunological background for the process of tumor growth is still obscure. However, our understanding of what happens
 could have important consequences, namely in the context of cancer immunotherapy. A tumor is able to grow in the host environment
 either because it is recognizable as normal tissue and tolerated by host immune cells, or because it can “escape” from host
 immunosurveillance. According to the second option the mechanisms of tumor recognition and consequent destruction are actively
 disturbed by such processes as: change of tumor immunogenicity, production of tumor-derived regulatory molecules, and interaction
 of cancer cells with tumor-infiltrating immune cells. The results of studies devoted to the problem of immunoregulation in
 the tumor envi...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4046272</comments>
            <pubDate>Tue, 05 Oct 2010 05:49:27 +0100</pubDate>
            <guid isPermaLink="false">4046272</guid>        </item>
        <item>
            <title>The Center of Accessibility: Dβ Control of V(D)J Recombination</title>
            <link>http://www.medworm.com/index.php?rid=4032182&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr7988xkm3wu37t37%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Developmental patterning of antigen receptor gene assembly in lymphocyte precursors correlates with decondensation of the
 chromatin surrounding individual gene segments. Ongoing V(D)J recombination is associated with hyperacetylation of histones
 H3 and H4 and the expression of sterile germline transcripts across the region of recombinational accessibility. Likewise,
 histone acetyltransferase and SWI/SNF chromatin remodeling complexes each appear to be required for recombination, and the
 PHD-finger of RAG-2 preferentially associates with recombination signal sequence (RSS) chromatin that contains H3 trimethylated
 on lysine 4. However, the regulatory mechanisms that direct chromatin alteration and rearrangement have proven elusive, due
 in large part to the interdepe...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4032182</comments>
            <pubDate>Sat, 02 Oct 2010 05:56:10 +0100</pubDate>
            <guid isPermaLink="false">4032182</guid>        </item>
        <item>
            <title>Iron and Immunity: Immunological Consequences of Iron Deficiency and Overload</title>
            <link>http://www.medworm.com/index.php?rid=4019014&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv2650044661v52p1%2F</link>
            <description>This article will review what is currently known about how disturbances of
 iron metabolism can affect immunity and how activation of the immune system can lead to alterations in iron balance.
 
 
	Content Type Journal ArticleDOI 10.1007/s00005-010-0095-9Authors
		Bobby J. Cherayil, Department of Pediatrics, Mucosal Immunology Laboratory, Massachusetts General Hospital, Harvard Medical School, Building 114, 16th Street, Charlestown, Boston, MA 02129, USA
	

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-4917Print ISSN 0004-069X (Source: Archivum Immunologiae et Therapiae Experimentalis)</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4019014</comments>
            <pubDate>Tue, 28 Sep 2010 05:49:51 +0100</pubDate>
            <guid isPermaLink="false">4019014</guid>        </item>
        <item>
            <title>Validation of Basophil CD164 Upregulation for Pollen Allergy Diagnosis</title>
            <link>http://www.medworm.com/index.php?rid=4019015&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F65537034102h64h7%2F</link>
            <description>This study was performed in 24 patients with allergy to
 grass pollens, and in 25 healthy controls. The protocol for allergen-induced basophil CD164 upregulation consisted of whole
 blood samples processing and staining with anti-CCR3/anti-CD164 antibodies added to a buffer at the beginning of stimulation.
 We observed dose-dependent allergen-induced basophil CD164 upregulation with 100% of specificity in both used allergen concentrations
 (12 and 1.2&amp;nbsp;ng/ml). Higher allergen concentration resulted in 100% and lower concentration in only 70.83% sensitivity. We
 have observed in the patients statistically significant correlations between anti-IgE stimulation and both allergen concentrations
 (for 12&amp;nbsp;ng/ml, r&amp;nbsp;=&amp;nbsp;0.71, p&amp;nbsp;&amp;lt;&amp;nbsp;0.0001; and for 1.2&amp;nbsp;ng/ml, r&amp;nbsp;...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4019015</comments>
            <pubDate>Mon, 27 Sep 2010 05:49:51 +0100</pubDate>
            <guid isPermaLink="false">4019015</guid>        </item>
        <item>
            <title>Dysregulation of Thymic Clonal Deletion and the Escape of Autoreactive T Cells</title>
            <link>http://www.medworm.com/index.php?rid=4014235&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fng3617128084726l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Events ongoing in the thymus are critical for deleting developing thymocytes specific for tissue antigens, and establishing
 self-tolerance within the T cell compartment. Aberrant thymic negative selection, however, is believed to generate a repertoire
 with increased self-reactivity, which in turn can contribute to the development of T cell-mediated autoimmunity. In this review,
 mechanisms that regulate the efficacy of negative selection and influence the deletion of autoreactive thymocytes will be
 discussed.
 
 
	Content Type Journal ArticleDOI 10.1007/s00005-010-0100-3Authors
		Charles J. Kroger, Department of Microbiology and Immunology, University of North Carolina, Mary Ellen Jones Bldg., Room 635, Campus Box 7290, Chapel Hill, NC 27599-7290, USARafael R. Flores...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4014235</comments>
            <pubDate>Sun, 26 Sep 2010 05:51:38 +0100</pubDate>
            <guid isPermaLink="false">4014235</guid>        </item>
        <item>
            <title>Flaws in the Medical Literature: Who’s to Blame?</title>
            <link>http://www.medworm.com/index.php?rid=4014237&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm27x364775217275%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s00005-010-0099-5Authors
		Jerome P. Kassirer, School of Medicine, Tufts University, 136 Harrison Ave., Boston, MA 02111, USA
	

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-4917Print ISSN 0004-069X (Source: Archivum Immunologiae et Therapiae Experimentalis)</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4014237</comments>
            <pubDate>Sun, 26 Sep 2010 05:51:37 +0100</pubDate>
            <guid isPermaLink="false">4014237</guid>        </item>
        <item>
            <title>Interleukin-27: Biological Properties and Clinical Application</title>
            <link>http://www.medworm.com/index.php?rid=4014236&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fww4227168721081t%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Interleukin (IL)-27 is a novel cytokine secreted by stimulated antigen-presenting cells. Initial studies on the biology of
 IL-27 provided evidence for its role in the initiation of TH1 responses; however, subsequent work has indicated that IL-27 has broad inhibitory effects on TH1, TH2, and TH17 subsets of T cells as well as the expansion of inducible regulatory T cells. The involvement of IL-27 in the regulation
 of angiogenesis and antiviral response has also recently been reported. The aim of this review is to highlight the potential
 areas of IL-27 clinical application, especially the management of neoplastic and viral diseases as well as autoimmune disorders,
 including rheumatoid arthritis and multiple sclerosis. The review will also serve to elaborate on the mol...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4014236</comments>
            <pubDate>Sun, 26 Sep 2010 05:51:37 +0100</pubDate>
            <guid isPermaLink="false">4014236</guid>        </item>
        <item>
            <title>Tumor-Resident CD8+ T-cell: The Critical Catalyst in IL-12-Mediated Reversal of Tumor Immune Suppression</title>
            <link>http://www.medworm.com/index.php?rid=4014238&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv0q5281307655026%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Tumor-resident T cells display a functionally impaired effector/memory (Tem) phenotype. Sustained intratumoral administration
 of IL-12, on the other hand, can restore cytolytic function to pre-existing CD8+ Tem, resulting in effective tumor kill. Whereas cytotoxic T lymphocytes (CTL) are generally assumed to mediate tumor regression
 via direct tumor cytotoxicity, recent work revealed that activated CD8+ Tem mobilize a systemic, multi-component effector cascade that includes both innate and adaptive immune mechanisms. Here
 we summarize these mechanisms, review how tumor-resident CD8+ Tem orchestrate this cascade and discuss the potential clinical implications of these findings.
 
 
	Content Type Journal ArticleDOI 10.1007/s00005-010-0097-7Authors
		Nejat K. Egilmez, D...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4014238</comments>
            <pubDate>Sun, 26 Sep 2010 05:51:35 +0100</pubDate>
            <guid isPermaLink="false">4014238</guid>        </item>
        <item>
            <title>Detection of β-Herpesviruses in Polish Adult Cord Blood Stem Cell Recipients by Real-Time PCR: Single Centre Study</title>
            <link>http://www.medworm.com/index.php?rid=4014239&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F971n2m5q4v311x32%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Umbilical cord blood transplantation (UCBT) is known to be associated with increased risk of infections, compared to bone
 marrow or peripheral blood stem cell transplantation. In viral diseases for which specific treatment is available, real-time
 PCR assays are reliable diagnostic tools for timely initiation of appropriate therapy and for rapid assessment of the efficacy
 of antiviral treatment strategies. A retrospective review of samples from a group of seven adult cord blood stem cell recipients
 was made. Serum samples taken up to 180&amp;nbsp;days after transplantation were examined with quantitative real-time PCR for measurement
 of viral load (CMV, HHV-6, and HHV-7). Cytomegalovirus (CMV) DNA was detected in samples taken from four patients (57%) in
 the period of ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4014239</comments>
            <pubDate>Sat, 25 Sep 2010 05:59:22 +0100</pubDate>
            <guid isPermaLink="false">4014239</guid>        </item>
        <item>
            <title>Genetic Modification of T Cells Improves the Effectiveness of Adoptive Tumor Immunotherapy</title>
            <link>http://www.medworm.com/index.php?rid=3862902&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F016463455l20186j%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Appropriate combinations of immunotherapy and gene therapy promise to be more effective in the treatment of cancer patients
 than either of these therapeutic approaches alone. One such treatment is based on the application of patients’ cytotoxic T
 cells, which can be activated, expanded, and genetically engineered to recognize particular tumor-associated antigens (TAAs).
 Because T cells recognizing TAAs might become unresponsive in the process of tumor development as a result of tumor evasion
 strategies, immunogenic viral antigens or alloantigens could be used for the expansion of cytotoxic T cells and then redirected
 through genetic engineering. This therapeutic approach has already demonstrated promising results in melanoma patients and
 could be used in the tre...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3862902</comments>
            <pubDate>Sat, 07 Aug 2010 07:04:40 +0100</pubDate>
            <guid isPermaLink="false">3862902</guid>        </item>
        <item>
            <title>Polymorphisms in the Genes Encoding TGF-β1, TNF-α, and IL-6 Show Association with Type 1 Diabetes Mellitus in the Slovak Population</title>
            <link>http://www.medworm.com/index.php?rid=3828571&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb8x734h0p2380272%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Numerous cytokines have been shown to participate in the pathogenesis of type 1 diabetes (T1D). As gene polymorphisms can
 influence cytokine production or function, they may potentially contribute to genetic predisposition to the disease. The aim
 of this study was therefore to investigate the role of 22 single nucleotide polymorphisms (SNPs) in 13 cytokine and cytokine
 receptor genes in genetic susceptibility to T1D. Polymerase chain reaction with sequence-specific primers was used to genotype
 cytokine SNPs and HLA-DRB1 alleles in 151 diabetics and 140 healthy individuals of Slovak origin. Univariate analysis showed
 that transforming growth factor (TGF)-β1 codon 10 TT homozygotes were significantly more susceptible to developing T1D than
 C allele carriers (P
 c&amp;n...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3828571</comments>
            <pubDate>Thu, 05 Aug 2010 13:28:47 +0100</pubDate>
            <guid isPermaLink="false">3828571</guid>        </item>
        <item>
            <title>Rebalancing Immune Specificity and Function in Cancer by T-Cell Receptor Gene Therapy</title>
            <link>http://www.medworm.com/index.php?rid=3817877&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy41246u363663285%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Adoptive immunotherapy with tumor-specific T lymphocytes has demonstrated clinical benefit in some cancers, particularly melanoma.
 Yet isolating and expanding tumor-specific cells from patients is challenging and there is limited ability to control T-cell
 affinity and response characteristics. T-cell receptor (TCR) gene therapy, in which T lymphocytes for immunotherapy are redirected
 using an introduced rearranged TCR, has emerged as an important alternative. Successful TCR gene therapy requires consideration
 of a number of issues, including TCR specificity and affinity, optimal gene therapy constructs, types of T cells administered,
 and the survival and activity of the modified cells. In this review we highlight the rationale for and experience with TCR
 gene ther...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3817877</comments>
            <pubDate>Mon, 02 Aug 2010 20:24:16 +0100</pubDate>
            <guid isPermaLink="false">3817877</guid>        </item>
        <item>
            <title>Biological Factors Involved in Implant-Anchored Orthodontics and in Prosthetic-Implant Therapy: A Literature Review</title>
            <link>http://www.medworm.com/index.php?rid=3809602&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl6x03mht5k3m01x2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;During the past few years, the application of orthodontic miniscrews and dental implants has been expanded. However, failures
 have necessitated ongoing investigation of potential risk factors. The aim of this overview was to conduct an assessment of
 the immunological response following application of cortical temporary anchorage devices—titanium miniscrew implants—in orthodontic
 patients. A scrupulous search of the database revealed only two matching items; therefore studies evaluating the immune response
 subsequent to insertion of dental implants were reviewed. Thorough assessment revealed the following as factors associated
 with dental implant rejection: (1) correlation of the volume of gingival and peri-implant crevicular fluid and the amount
 of interleukin...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3809602</comments>
            <pubDate>Fri, 30 Jul 2010 17:06:24 +0100</pubDate>
            <guid isPermaLink="false">3809602</guid>        </item>
        <item>
            <title>Autoimmune Versus Oligodendrogliopathy: The Pathogenesis of Multiple Sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=3809603&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc544122qr4l6t084%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Multiple sclerosis (MS) is the most common inflammatory demyelinating disease of the central nervous system (CNS); it affect
 millions of patients worldwide and the number of patients is on the rise. Current treatment options are fairly limited and
 there is a strong unmet need for disease-targeted therapies for MS. The most widely accepted hypothesis for the pathogenesis
 of MS is that it is a primary autoimmune disease in which myelin-specific T cells play a central role in the progression of
 demyelination. According to this hypothesis, a powerful immune suppression or a reconstruction of the immune system to abrogate
 disease-specific leukocytes early in the development of the disease is expected to halt or even reverse the disease, since
 remyelination is an except...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3809603</comments>
            <pubDate>Fri, 30 Jul 2010 17:06:23 +0100</pubDate>
            <guid isPermaLink="false">3809603</guid>        </item>
        <item>
            <title>Monocyte and Macrophage Abnormalities in Systemic Lupus Erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=3809604&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk333257070314052%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with profound effects on multiple organ systems. In patients
 with SLE, the immune system is subverted to target numerous self antigens and the ensuing inflammatory response elicits a
 vicious cycle of immune-cell activation and tissue damage. Both genetic and environmental factors are essential for the development
 of this debilitating condition, although the exact cause remains unclear. Early studies on the pathogenesis of lupus centered
 on the adaptive immune system as lymphocyte abnormalities were thought to be the primary cause of autoimmunity. In the past
 decade, however, this paradigm has shifted with rapid advances in the field of innate immunity. These developments have yielded
 important insi...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3809604</comments>
            <pubDate>Fri, 30 Jul 2010 17:06:22 +0100</pubDate>
            <guid isPermaLink="false">3809604</guid>        </item>
        <item>
            <title>Antimicrobial Peptides in the Brain</title>
            <link>http://www.medworm.com/index.php?rid=3808004&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmm762812m66554v6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Antimicrobial peptides (AMPs) are an evolutionarily conserved component of the innate immune system of many species. The brain
 is an immunologically privileged organ but can produce a robust immune response against pathogens and cell debris, promoting
 rapid and efficient clearance. AMPs may be critically involved in the innate immune system of the brain. Though the mechanisms
 of AMPs’ action in the brain still need further elucidation, many studies have shown that AMPs are multifunctional molecules
 in the brain. In addition to antimicrobial action, they take part in congenital and adaptive immune reactions (immunoregulation),
 function as signaling molecules in tissue repair, inflammation and other important processes through different mechanisms,
 and they might,...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3808004</comments>
            <pubDate>Thu, 29 Jul 2010 16:07:55 +0100</pubDate>
            <guid isPermaLink="false">3808004</guid>        </item>
        <item>
            <title>The Incidence and Significance of Pattern-Recognition Receptors in Chronic Viral Hepatitis Types B and C in Man</title>
            <link>http://www.medworm.com/index.php?rid=3653312&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjj5127r355w443pk%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic viral hepatitis B and C are among the most common and devastating liver diseases worldwide. Immune response plays
 a crucial role in the course of both diseases. In spite of the importance of the adaptive arm of the immune response, there
 is a growing role of innate immunity, the earliest confronted with viral attack. Pattern-recognition receptors (PRRs) and,
 in particular, Toll-like receptors (TLRs) are molecules which are able not only to recognize foreign invaders, but also quickly
 mount an antiviral defense. Activation of PRRs has been demonstrated in both hepatitis types, i.e. in situ in the liver and
 on while blood cells. Both viruses, HCV and HBV, are able to subvert the PRR-mediated antiviral response by means of various
 proteins and enzymes. HCV ac...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3653312</comments>
            <pubDate>Wed, 09 Jun 2010 09:23:47 +0100</pubDate>
            <guid isPermaLink="false">3653312</guid>        </item>
        <item>
            <title>Immunomodulatory Effects of IFN-β and Lovastatin on Immunophenotype of Monocyte-Derived Dendritic Cells in Multiple Sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=3649541&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F65175061442374nn%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Multiple sclerosis (MS) is an autoimmune disease of the central nervous system and current MS treatment is only partially
 effective. Recent data suggest that statins may be potent immunomodulatory agents. In order to evaluate their role in MS,
 we analyzed the in vitro effects of interferon (IFN)-β and lovastatin on the differentiation and maturation of monocyte-derived
 dendritic cells (DCs) of MS patients. Twenty-seven patients with relapsing–remitting MS were recruited for the study. DC differentiation
 and maturation were evaluated based on surface phenotypic changes and the expressions of CD14, CD83, CD1a, CD80, CD86, CD206,
 and C209 were analyzed by flow cytometry. The results showed that IFN-β and lovastatin affect DC phenotype. Both agents decrease
 the ex...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3649541</comments>
            <pubDate>Mon, 07 Jun 2010 16:04:39 +0100</pubDate>
            <guid isPermaLink="false">3649541</guid>        </item>
        <item>
            <title>Human Mast Cells and Mastocytosis: Harnessing MicroRNA Expression as a New Approach to Therapy?</title>
            <link>http://www.medworm.com/index.php?rid=3626656&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdg46631687144242%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;MicroRNAs (miRNAs) are short, non-coding RNAs that have emerged as key post-transcriptional regulators in a wide variety of
 organisms and critical cellular processes. Because any one miRNA can regulate the expression of a distinct set of genes, differential
 miRNA expression can shape the repertoire of proteins that are actually expressed during development, differentiation, or
 disease. To understand what goes wrong when a cell becomes transformed requires knowledge of the processes that ensure normal
 development. It is now clear that miRNAs may act as oncogenes and/or tumor suppressors within gene regulatory networks, thereby
 contributing to the development of cancer. Mast cells are long-lived cells, widely distributed throughout vascularized tissues,
 in particula...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3626656</comments>
            <pubDate>Sat, 29 May 2010 05:46:47 +0100</pubDate>
            <guid isPermaLink="false">3626656</guid>        </item>
        <item>
            <title>Don’t Get Spooked! How to Collaborate with a Professional Medical Communicator (And Avoid Ghostwriting)</title>
            <link>http://www.medworm.com/index.php?rid=3626657&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F71274t6kux7u8105%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Substantial confusion exists about the role of medical writers and editors (hereafter, medical communicators) in medical publication.
 Much of the confusion is due to the failure to recognize the difference between terms. Ghostwriting is unethical, whereas
 professional medical communication refers to legitimate writing and editing services provided by individuals who comply with
 ethical guidelines. The purpose of this article is to shed light on this subject by reviewing relevant guidelines and by providing
 practical tips for authors interested in collaborating with medical communicators. Specifically, this article addresses a
 series of questions, such as what to expect from medical communicators, how to evaluate them, and how to collaborate ethically
 and efficient...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3626657</comments>
            <pubDate>Fri, 28 May 2010 15:12:30 +0100</pubDate>
            <guid isPermaLink="false">3626657</guid>        </item>
        <item>
            <title>Impact of Human IgA Antibodies on Complement-Dependent Cytotoxicity Mediated by Combinations of EGF-R-Directed Antibodies</title>
            <link>http://www.medworm.com/index.php?rid=3610908&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu463443875665644%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Dual combinations of non-crossblocking epidermal growth factor receptor (EGF-R)-directed monoclonal antibodies were demonstrated
 to effectively induce complement-dependent cytotoxicity (CDC) of tumor cells, whereas individual antibodies were ineffective.
 Here the modulating effects of different antibody isotypes on CDC were studied by adding them as a third antibody. Two different
 combinations of non-crossblocking EGF-R antibodies of human IgG1 isotype, 018/003 and 425/005, were investigated against the
 A431 and A1207 cell lines. As a third antibody, human IgG1, IgA1, and IgA2 isotype variants of the therapeutic EGF-R antibody
 225 were employed that bind to an EGF-R epitope distinct from the other EGF-R antibodies. In this model, the human IgG1 antibody
 proved to ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3610908</comments>
            <pubDate>Thu, 27 May 2010 16:57:47 +0100</pubDate>
            <guid isPermaLink="false">3610908</guid>        </item>
        <item>
            <title>Intercellular Exchange of Surface Molecules and its Physiological Relevance</title>
            <link>http://www.medworm.com/index.php?rid=3610909&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb262055147485025%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;For many decades, cellular immunologists have relied on the expression of various cell surface molecules to divide cells into
 different types and subtypes to study their function. However, in recent years, a large and fast-expanding body of work has
 described the transfer of surface molecules, including MHC class I and II molecules, between cells, both in vitro and in vivo.
 The function of this process is still largely unknown, but it is likely to have a significant role in the control of the immune
 system. It is also likely that this process takes place in a regulated rather than stochastic manner, thus providing another
 way for the immune system to orchestrate its function. In this review we will summarize the key findings so far, examining
 the mechanisms of tra...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3610909</comments>
            <pubDate>Thu, 27 May 2010 16:57:46 +0100</pubDate>
            <guid isPermaLink="false">3610909</guid>        </item>
        <item>
            <title>Recent Developments in Immune Activation by Uric Acid Crystals</title>
            <link>http://www.medworm.com/index.php?rid=3610910&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8q5w84573h645156%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Uric acid crystals, the causative agent of gout, have recently gained widespread attention due to their role as a natural
 endogenous adjuvant. Uric acid crystals, first sensed extracellularly by membrane lipid alterations, are internalized and
 subsequently activate the NLRP3 inflammasome. Currently, various aspects of this particular novel pathway are poorly defined.
 This short review will focus on some recent discoveries regarding this simple crystalline structure and address areas requiring
 further investigation. The fact that uric acid crystals activate innate host defense mechanisms, triggering robust inflammation
 and immune activation, may lead to engineering potent adjuvants for future vaccines. Furthermore, the elucidation of uric
 acid’s mechanism of infl...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3610910</comments>
            <pubDate>Wed, 26 May 2010 14:49:46 +0100</pubDate>
            <guid isPermaLink="false">3610910</guid>        </item>
        <item>
            <title>Slime Production by Staphylococcus aureus and Staphylococcus epidermidis Strains Isolated from Patients with Diabetic Foot Ulcers</title>
            <link>http://www.medworm.com/index.php?rid=3610911&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpk7t132t3071421h%2F</link>
            <description>In conclusion, PIA production is a very common trait of S. aureus and S. epidermidis isolates obtained from diabetic foot ulcer patients.
 
 
	Content Type Journal ArticleCategory Short CommunicationDOI 10.1007/s00005-010-0079-9Authors
		Adrianna Podbielska, Polish Academy of Sciences Department of Surgical Research and Transplantology, Mossakowski Medical Research Center Pawińskiego 5 02-106 Warsaw PolandHanna Galkowska, Polish Academy of Sciences Department of Surgical Research and Transplantology, Mossakowski Medical Research Center Pawińskiego 5 02-106 Warsaw PolandEwa Stelmach, Polish Academy of Sciences Department of Surgical Research and Transplantology, Mossakowski Medical Research Center Pawińskiego 5 02-106 Warsaw PolandGrazyna Mlynarczyk, Medical University of Warsaw Departme...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3610911</comments>
            <pubDate>Wed, 26 May 2010 14:49:45 +0100</pubDate>
            <guid isPermaLink="false">3610911</guid>        </item>
        <item>
            <title>Hypoxia-inducible Factor 1 as one of the “Signaling Drivers” of Toll-like Receptor-Dependent and Allergic Inflammation</title>
            <link>http://www.medworm.com/index.php?rid=3610912&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7644332735n8n278%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric transcription complex which plays a crucial role in cellular adaptation
 to low oxygen availability. In the last years there has been increasing evidence about the role of this factor in inflammatory/innate
 immune reactions. It has also been found to contribute to different types of allergic inflammation. In this review the current
 knowledge about the accumulation and role of HIF-1 in Toll-like receptor-mediated and allergic inflammation is summarized.
 Differential biochemical mechanisms employed to stabilize the protein in different cases are discussed.
 
 
	Content Type Journal ArticleCategory REVIEWDOI 10.1007/s00005-010-0083-0Authors
		Vadim V. Sumbayev, University of Kent Medway School of Pharmacy Anson Build...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3610912</comments>
            <pubDate>Wed, 26 May 2010 14:49:44 +0100</pubDate>
            <guid isPermaLink="false">3610912</guid>        </item>
        <item>
            <title>B Cells: From Early Development to Regulating Allergic Diseases</title>
            <link>http://www.medworm.com/index.php?rid=3561062&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2327123846r76172%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;B lymphocytes are characterized by a unique and highly specialized developmental pathway that is responsible for their vast
 phenotypic and function diversity. B cell development is strictly regulated to ensure sufficient specific humoral immunity
 while at the same time avoiding any errors that would compromise B cell functionality. The generation and maintenance of mature
 B cells from the constant flux of bone marrow progenitors is a complex process that is generally poorly understood, although
 great progress has been made in recent years. B cells have for long been considered mainly as antibody-producing cells and
 therefore believed to play an important role in the pathophysiology of allergic diseases, primarily through their ability
 to produce IgE antibodies. Ho...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3561062</comments>
            <pubDate>Tue, 11 May 2010 08:14:24 +0100</pubDate>
            <guid isPermaLink="false">3561062</guid>        </item>
        <item>
            <title>Comparison of Three Methods of DNA Extraction in Endocervical Specimens for Chlamydia trachomatis Infection by Spectrophotometry, Agarose Gel, and PCR</title>
            <link>http://www.medworm.com/index.php?rid=3481253&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh3k2u261u752t7k0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 Chlamydia trachomatis is the major cause of sexually transmitted disease in the world. The aim of this study was to determine the best method of
 DNA extraction for detecting C. trachomatis by polymerase chain reaction (PCR) in sexually active women (n&amp;nbsp;=&amp;nbsp;80) attending Shahid Beheshti Hospital in Isfahan, Iran. Endocervical swabs were collected from 80 women, 22 of whom were
 asymptomatic and 58 symptomatic. Three different DNA extraction methods were used in this study (phenol-chlorophorm, proteinase
 K, and boiling). DNA yield was evaluated by spectrophotometry, agarose gel, and PCR. The internal control was assayed by β-globin
 primers (PCO4, GH20). The DNA cryptic plasmid was selected as the target for C. trachomatis and samples were examined by PCR usin...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3481253</comments>
            <pubDate>Fri, 16 Apr 2010 05:43:29 +0100</pubDate>
            <guid isPermaLink="false">3481253</guid>        </item>
        <item>
            <title>Microbiological Findings and Treatment of EBV-Associated Hemophagocytic Lymphohistiocytosis: A Case Report</title>
            <link>http://www.medworm.com/index.php?rid=3468832&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1h350337083jnl39%2F</link>
            <description>This report describes the detection and treatment of EBV-associated HLH in the case of a 17-year-old male. Serum samples and
 skin swabs were tested for the presence of viral DNA using real-time PCR techniques. To confirm the molecular biological tests,
 electron microscopy was also performed. EBV DNA was detected with real-time PCR in both blood samples and skin swabs. The
 level of viral DNA constantly decreased during the applied therapy. The presence of the virus in the skin was confirmed by
 the appearance of herpes virus-like particles detected by electron microscopy in fluid taken from skin ulcerations. The results
 show that in terms of treatment, special therapeutic measures are required to control the cytokine storm generated by EBV
 and to suppress proliferating EBV genome-conta...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3468832</comments>
            <pubDate>Mon, 12 Apr 2010 05:34:22 +0100</pubDate>
            <guid isPermaLink="false">3468832</guid>        </item>
        <item>
            <title>Experimental Anticancer Therapy with Vascular-disruptive Peptide and Liposome-entrapped Chemotherapeutic Agent</title>
            <link>http://www.medworm.com/index.php?rid=3468833&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff525104k65322k1q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Vasculature is essential for the sustained growth of solid tumors and metastases. Tumor cells surviving vascular-disruptive
 therapeutic intervention (especially those present at the tumor rim) can contribute to tumor regrowth. The aim was to strengthen,
 by carrier-mediated delivery of a chemotherapeutic, the curative effects of a bifunctional anti-vascular oligopeptide capable
 of inducing vascular shutdown and tumor shrinkage. For the in vitro experiments and animal therapy, ACDCRGDCFC-GG-D(KLAKLAK)2 peptide (900&amp;nbsp;μM in D-PBSA, i.e. Dulbecco’s PBS without Ca2+ and Mg2+) and size-calibrated, passively or actively targeted liposomes based on distearoylphosphatidylcholine, cholesterol, and N-carbamoyl-methoxypolyethyleneglycol coupled to distearoylphosphatidyleth...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3468833</comments>
            <pubDate>Sun, 11 Apr 2010 05:51:35 +0100</pubDate>
            <guid isPermaLink="false">3468833</guid>        </item>
        <item>
            <title>Erratum to: Complement: Coming Full Circle</title>
            <link>http://www.medworm.com/index.php?rid=3468834&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg5468q2801077j82%2F</link>
            <description>Content Type Journal ArticleCategory ErratumDOI 10.1007/s00005-010-0078-xAuthors
		Gaëlle Le Friec, MRC Centre for Transplantation King’s College London Guy’s Hospital 5th Floor Tower Wing, Great Maze Pond London SE1 9RT UKClaudia Kemper, MRC Centre for Transplantation King’s College London Guy’s Hospital 5th Floor Tower Wing, Great Maze Pond London SE1 9RT UK
	

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-4917Print ISSN 0004-069X (Source: Archivum Immunologiae et Therapiae Experimentalis)</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3468834</comments>
            <pubDate>Sat, 10 Apr 2010 07:51:18 +0100</pubDate>
            <guid isPermaLink="false">3468834</guid>        </item>
        <item>
            <title>Regulatory T Cell as a Target for Cancer Therapy</title>
            <link>http://www.medworm.com/index.php?rid=3450407&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy6678825g7152932%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Advances in our understanding of CD4+CD25+Foxp3+ regulatory T cells (TRegs) enabled the characterization of their activities in maintaining peripheral tolerance, preventing autoimmune diseases, and
 limiting chronic inflammatory diseases. Ironically, an effective action of these cells during tumor development can limit
 beneficial responses by suppressing immunity and limiting antitumor resistance, whereas one of the main functions of the immune
 system is to eliminate malignant cells. During the last years, the immunological role, mechanism of action, and clinical importance
 of these cells were profoundly characterized and the relationship between this subset of lymphocytes and cancerous cells arises
 as a key factor that influences tumor development. Recent insights ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3450407</comments>
            <pubDate>Wed, 07 Apr 2010 06:51:54 +0100</pubDate>
            <guid isPermaLink="false">3450407</guid>        </item>
        <item>
            <title>Adoptive T-cell Immunotherapy of Cancer Using Chimeric Antigen Receptor-Grafted T Cells</title>
            <link>http://www.medworm.com/index.php?rid=3450408&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F023km552316j4301%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Harnessing the power of the immune system to target cancer has long been a goal of tumor immunologists. One avenue under investigation
 is the modification of T cells to express a chimeric antigen receptor (CAR). Expression of such a receptor enables T-cell
 specificity to be redirected against a chosen tumor antigen. Substantial research in this field has been carried out, incorporating
 a wide variety of malignancies and tumor-associated antigens. Ongoing investigations will ensure this area continues to expand
 at a rapid pace. This review will explain the evolution of CAR technology over the last two decades in addition to detailing
 the associated benefits and disadvantages. The outcome of recent phase I clinical trials and the impact that these have had
 upon the ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3450408</comments>
            <pubDate>Tue, 06 Apr 2010 18:26:47 +0100</pubDate>
            <guid isPermaLink="false">3450408</guid>        </item>
        <item>
            <title>Involvement of Envelope-Glycoprotein Glycans in HIV-1 Biology and Infection</title>
            <link>http://www.medworm.com/index.php?rid=3450409&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc103k6885407004l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Infection of host cells with HIV-1 depends on a highly glycosylated virus envelope glycoprotein (Env) and host-cell receptors.
 Glycans participate substantially in Env folding and in the binding of virions to the host-cell surface and indirectly affect
 cellular uptake of HIV-1. Moreover, Env glycans could protect HIV-1 from host’s neutralizing antibodies, but some glycans,
 on the other hand, represent targets for neutralizing antibodies. Variability of Env and its glycans in the HIV-1 strains
 from around the world as well as in patients during disease progression contributes substantially to further HIV-1 spreading
 in spite of the progress in basic HIV-1 research, vaccine development, and highly active antiretroviral therapy of HIV-1 infections.
 
 
	Content Type...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3450409</comments>
            <pubDate>Mon, 05 Apr 2010 21:36:12 +0100</pubDate>
            <guid isPermaLink="false">3450409</guid>        </item>
        <item>
            <title>Plasma TNF-α and IL-10 Level-Based Prognostic Model Predicts Outcome of Patients with Diffuse Large B-Cell Lymphoma in Different Risk Groups Defined by the International Prognostic Index</title>
            <link>http://www.medworm.com/index.php?rid=3315404&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F81gm22q665v36628%2F</link>
            <description>In this study the impact of combined
 elevation of TNF-α and IL-10 on disease features and outcome of patients with diffuse large B-cell lymphoma (DLBCL) were investigated.
 Plasma TNF-α and IL-10 levels were determined at the time of diagnosis in a group of 106 DLBCL patients uniformly treated
 with anthracycline-based regimens. Three risk groups depending on the pretreatment levels of the cytokines were identified:
 low-, intermediate-, and high-risk groups. In univariate analysis, the cytokine intermediate- and high-risk groups were associated
 with lower probability of achieving a complete remission (odds ratio [OR]&amp;nbsp;=&amp;nbsp;0.2, 95% confidence interval [CI] 0.06–0.6, p&amp;nbsp;=&amp;nbsp;0.006 and OR&amp;nbsp;=&amp;nbsp;0.05, 95% CI 0.01–0.2, p&amp;nbsp;&amp;lt;&amp;nbsp;0.0001, respectively) and short...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3315404</comments>
            <pubDate>Fri, 26 Feb 2010 09:44:08 +0100</pubDate>
            <guid isPermaLink="false">3315404</guid>        </item>
        <item>
            <title>Nanogram Doses of Alum-Adjuvanted HBs Antigen Induce Humoral Immune Response in Mice When Orally Administered</title>
            <link>http://www.medworm.com/index.php?rid=3284916&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft25584101187v731%2F</link>
            <description>The objective
 of this study was to evaluate the effect of dose and timing of orally delivered alum-adsorbed antigen on the magnitude of
 the anti-HBs humoral response. Mice were immunized orally by gavage intubation or parenterally by intramuscular injection
 three times, once every 2&amp;nbsp;weeks, with doses of 5, 50, or 500&amp;nbsp;ng alum-adjuvanted HBsAg. A low dose (10&amp;nbsp;ng) of HBsAg was orally
 administered three times in different time intervals: 2, 4, 6, and 8&amp;nbsp;weeks. The three consecutive 5-ng oral doses of the antigen
 induced immune response at the protective level (≥10&amp;nbsp;mIU/ml), significantly higher than the reaction elicited by three 50
 or 500&amp;nbsp;ng doses. In contrast, intramuscular delivery of these doses did not differ significantly; however, they induced a
 five...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284916</comments>
            <pubDate>Wed, 17 Feb 2010 18:33:50 +0100</pubDate>
            <guid isPermaLink="false">3284916</guid>        </item>
        <item>
            <title>Dysregulation of the Receptor Activator of NF-κB Ligand and Osteoprotegerin Production Influence the Apoptosis of Multiple Myeloma Patients’ Bone Marrow Stromal Cells Co-Cultured with Myeloma Cells</title>
            <link>http://www.medworm.com/index.php?rid=3280851&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4kp11p7657360204%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The interaction of multiple myeloma (MM) cells and bone marrow stromal cells (BMSCs) induces profound changes in the bone
 marrow environment, influencing osteoclastogenesis and MM cell survival. Differences in receptor activator of NF-κB ligand
 (RANKL) and osteoprotegerin (OPG) production in BMSCs derived from MM patients and control subjects and the apoptosis of BMSCs
 and MM cells in co-cultures of both cell types were examined. RANKL and OPG expressions were examined by ELISA and semiquantitative
 RT-PCR. Apoptosis of BMSCs after contact with RPMI8226 and U266 cells was measured by flow cytometry and the level of ALP
 activity by the spectrophotometric method. OPG production by BMSCs was significantly inhibited after direct contact with RPMI8226
 cells. Production...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3280851</comments>
            <pubDate>Tue, 16 Feb 2010 06:44:46 +0100</pubDate>
            <guid isPermaLink="false">3280851</guid>        </item>
        <item>
            <title>CD4+ T Cell Epitope Discovery and Rational Vaccine Design</title>
            <link>http://www.medworm.com/index.php?rid=3273404&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F86632579171r4225%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;T cell epitope-driven vaccine design employs bioinformatic algorithms to identify potential targets of vaccines against infectious
 diseases or cancer. Potential epitopes can be identified with major histocompatibility complex (MHC)-binding algorithms, and
 the ability to bind to MHC class I or class II indicates a predominantly CD4+ or CD8+ T cell response. Furthermore, an epitope-based vaccine can circumvent evolutionary events favoring immune escape present
 in native proteins from pathogens. It can also focus on only the most relevant epitopes (i.e. conserved and promiscuous) recognized
 by the majority of the target population. Mounting evidence points to the critical role of CD4+ T cells in natural antigen encounter and active immunization. In this paper the need ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3273404</comments>
            <pubDate>Sun, 14 Feb 2010 06:52:07 +0100</pubDate>
            <guid isPermaLink="false">3273404</guid>        </item>
        <item>
            <title>P2X7 Receptor Signaling Pathway as a Therapeutic Target for Neurodegenerative Diseases</title>
            <link>http://www.medworm.com/index.php?rid=3263680&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F378x400v3l18j230%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A recent study suggested that neuroinflammation plays a major role in the pathogenesis of a number of neurodegenerative diseases
 such as Alzheimer’s disease and Parkinson’s disease. Although the precise mechanism is obscure, dysregulation of the signaling
 transduction pathway in microglia may enhance inflammation, leading to synaptic dysfunction and ultimately to neuronal cell
 death. The expression and function of the P2X7 receptor (P2X7R), an ATP-gated ion channel abundantly expressed in microglia
 in the brain, is significantly up-regulated in the postmortem brain of Alzheimer’s disease patients and various neurodegenerative
 disease animal models. This supports the role of the P2X7R pathway in the progression of neurodegeneration. Blocking P2X7R
 using brill...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3263680</comments>
            <pubDate>Tue, 09 Feb 2010 06:47:59 +0100</pubDate>
            <guid isPermaLink="false">3263680</guid>        </item>
        <item>
            <title>Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential</title>
            <link>http://www.medworm.com/index.php?rid=3255679&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F725574uvq7552u2g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The concept of gene therapy originated in the mid twentieth century and was perceived as a revolutionary technology with the
 promise to cure almost any disease of which the molecular basis was understood. Since then, several gene vectors have been
 developed and the feasibility of gene therapy has been shown in many animal models of human disease. However, clinical efficacy
 could not be demonstrated until the beginning of the new century in a small-scale clinical trial curing an otherwise fatal
 immunodeficiency disorder in children. This first success, achieved after retroviral therapy, was later overshadowed by the
 occurrence of vector-related leukemia in a significant number of the treated children, demonstrating that the future success
 of gene therapy depends on...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3255679</comments>
            <pubDate>Mon, 08 Feb 2010 17:20:20 +0100</pubDate>
            <guid isPermaLink="false">3255679</guid>        </item>
        <item>
            <title>The Role of Thymic Stromal Lymphopoietin in Allergic Inflammation and Chronic Obstructive Pulmonary Disease</title>
            <link>http://www.medworm.com/index.php?rid=3255678&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff0n76065x008l304%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Thymic stromal lymphopoietin (TSLP) primes dendritic cells to promote a Th2 inflammatory response. Its action is mediated
 by a heterodimeric receptor which consists of the interleukin-7 receptor α chain and the TSLP receptor chain (TSLPR). TSLPR
 resembles the common γ chain subunit utilized by many type 1 cytokine receptors. Normal epithelial cells, keratinocytes, and
 stromal cells constitutively express TSLP. Dendritic cells that are activated by TSLP promote the development of CD4+ T cells into pro-inflammatory Th2 cells. TSLP thus plays a potentially important role in the pathogenesis of allergic inflammation
 in asthma and atopic dermatitis. TSLP also has direct effects on other types of cells in the bronchial mucosa. It is over-expressed
 in the bronchial muco...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3255678</comments>
            <pubDate>Mon, 08 Feb 2010 17:20:20 +0100</pubDate>
            <guid isPermaLink="false">3255678</guid>        </item>
        <item>
            <title>Immunoprophylaxis of Tuberculosis: An Update of Emerging Trends</title>
            <link>http://www.medworm.com/index.php?rid=3255680&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr003415043541123%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Developing effective prophylactics to combat tuberculosis is currently in an exploratory stage. The HIV pandemic and emergence
 of multi- and extensively drug-resistant strains of Mycobacterium tuberculosis indicate that the current preventive measures against this ever-evolving pathogen are inadequate. The currently available
 vaccine BCG in its present form affords variable protection which usually wanes with aging. Various reasons have been cited
 to explain the discrepancies in the efficacy of BCG, including generic differences in the different BCG vaccine strains used
 in immunization program throughout the world. The low efficacy of BCG vaccine has promoted the search for novel vaccines for
 tuberculosis. The search strategies aim at completely replacing the exist...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3255680</comments>
            <pubDate>Sat, 06 Feb 2010 18:09:32 +0100</pubDate>
            <guid isPermaLink="false">3255680</guid>        </item>
        <item>
            <title>Different Facets of Competition in the Pharmaceutical Sector: Preliminary Findings of the European Commission’s Sector Inquiry into Pharmaceuticals</title>
            <link>http://www.medworm.com/index.php?rid=3223898&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq71569u8701t2m63%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The pharmaceutical sector is a part of today’s economy in which the relationship between patents and competition has been
 receiving increasing attention. The European Commission’s inquiry into this sector adds to the ongoing debate. Its Preliminary
 Report, published in November 2008, explains and quantifies a number of practices adopted by individual companies operating
 in the sector. The Report focuses on two strands of interplay between pharmaceutical companies. The first focus is on competition
 between originator and generic companies and the second relates to competition among originators themselves. The Report’s
 observations on the former provide us with some important insights into the potential ways of raising barriers to the timely
 entry of cheaper, ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3223898</comments>
            <pubDate>Wed, 27 Jan 2010 19:58:53 +0100</pubDate>
            <guid isPermaLink="false">3223898</guid>        </item>
        <item>
            <title>In Vitro Photodynamic Therapy with Chlorin e6 Leads to Apoptosis of Human Vascular Smooth Muscle Cells</title>
            <link>http://www.medworm.com/index.php?rid=3190239&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F13420rw401t1v054%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Percutaneous coronary intervention has become the most common and widely implemented method of heart revascularization. However,
 the development of restenosis remains the major limitation of this method. Photodynamic therapy (PDT) recently emerged as
 a new and promising method for the prevention of arterial restenosis. Here the efficacy of chlorin e6 in PDT was investigated
 in vitro using human vascular smooth muscle cells (TG/HA-VSMCs) as one of the cell types crucial in the development of restenosis.
 PDT-induced cell death was studied on many levels, including annexin V staining, measurement of the generation reactive oxygen
 species (ROS) and caspase-3 activity, and assessment of changes in mitochondrial membrane potential and fragmentation of DNA.
 Photosensitiz...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3190239</comments>
            <pubDate>Fri, 15 Jan 2010 00:46:50 +0100</pubDate>
            <guid isPermaLink="false">3190239</guid>        </item>
        <item>
            <title>Revisiting the Natural History of Tuberculosis</title>
            <link>http://www.medworm.com/index.php?rid=3154064&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk448311888515p68%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Once Mycobacterium tuberculosis infects a person it can persist for a long time in a process called latent tuberculosis infection (LTBI). LTBI has traditionally
 been considered to involve the bacilli remaining in a non-replicating state (dormant) in old lesions but still retaining their
 ability to induce reactivation and cause active tuberculosis (TB) once a disruption of the immune response takes place. The
 present review aims to challenge these concepts by including recent experimental data supporting LTBI as a constant endogenous
 reinfection process as well as the recently introduced concepts of damage-response and tolerance frameworks to explain TB
 induction. These frameworks highlight the key role of an exaggerated and intolerant host response against M. tuber...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3154064</comments>
            <pubDate>Mon, 04 Jan 2010 18:01:00 +0100</pubDate>
            <guid isPermaLink="false">3154064</guid>        </item>
        <item>
            <title>Serodiagnostic Efficacy of Mycobacterium tuberculosis 30/32-kDa Mycolyl Transferase Complex, ESAT-6, and CFP-10 in Patients with Active Tuberculosis</title>
            <link>http://www.medworm.com/index.php?rid=3154066&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftp04g2x2k082642x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Elimination of tuberculosis (TB) largely depends upon definitive rapid diagnosis and treatment. Widely used diagnostic tests
 do not qualify for use in a developing country due to lack of either desired accuracy or their cost. In the present study
 an enzyme-linked immunosorbent assay was used to evaluate the diagnostic potential of an immuno-dominant 30/32-kDa mycolyl
 transferase complex (Ag85 complex) and Mycobacterium tuberculosis-specific proteins (ESAT-6 and CFP-10) of the RD1 region. Higher sensitivity (84.1%) with Ag85 complex was observed compared
 with ESAT-6 (64.9%) and CFP-10 (66%), with almost similar specificity (Ag85: 85.2%, ESAT-6: 88.9%, CFP-10: 85.2%), whereas
 the individual components of Ag85 complex, i.e. Ag85A, Ag85B, and Ag85C, showed sensitivitie...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3154066</comments>
            <pubDate>Mon, 04 Jan 2010 18:00:59 +0100</pubDate>
            <guid isPermaLink="false">3154066</guid>        </item>
        <item>
            <title>Role of SLAM-Associated Protein in the Pathogenesis of Autoimmune Diseases and Immunological Disorders</title>
            <link>http://www.medworm.com/index.php?rid=3154065&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb07566715k53517p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Signaling lymphocytic activation molecule (SLAM)-associated protein (SAP) is an adaptor molecule containing a Src homology
 2 (SH2) domain. SAP is expressed in T cells and natural killer (NK) cells and binds to the cytoplasmic domains of SLAM family
 receptors, resulting in the subsequent recruitment of Fyn. The SAP (SH2D1A) gene is located on the X chromosome and is responsible for X-linked lymphoproliferative disease, characterized by higher
 susceptibility to Epstein-Barr virus infection. The SAP-mediated signal is not only essential for the development of NKT cells,
 i.e. unconventional CD1d-restricted T cells with invariant Vα14 T cell receptors, but also for the regulation of the function
 of NK cells and conventional T cells. The role of SAP-mediated signaling i...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3154065</comments>
            <pubDate>Mon, 04 Jan 2010 18:00:59 +0100</pubDate>
            <guid isPermaLink="false">3154065</guid>        </item>
        <item>
            <title>Immunotherapy of Rheumatoid Arthritis Targeting Inflammatory Cytokines and Autoreactive T Cells</title>
            <link>http://www.medworm.com/index.php?rid=3154067&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9205604172075227%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Rheumatoid arthritis is a chronic disorder for which there is no known cure. Concentrating on specific elements of the abnormal
 immune response that characterizes the disease, scientists are reaching into biotechnology’s bag of tricks to develop immunotherapeutic
 techniques. This paper will present some advances in the immunotherapy of rheumatoid arthritis targeting inflammatory cytokines
 and autoreactive T cells.
 
	Content Type Journal ArticleCategory ReviewDOI 10.1007/s00005-009-0058-1Authors
		Guangjie Chen, Shanghai Jiao Tong University School of Medicine Department of Immunology, Institutes of Medical Sciences 280 South Chongqing Road Shanghai 200025 People’s Republic of China
	

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3154067</comments>
            <pubDate>Mon, 04 Jan 2010 18:00:53 +0100</pubDate>
            <guid isPermaLink="false">3154067</guid>        </item>
        <item>
            <title>The Enzymatic Activity of Type 1 Iodothyronine Deiodinase (D1) is Low in Liver Hemangioma: A Preliminary Study</title>
            <link>http://www.medworm.com/index.php?rid=3154068&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq741158423638337%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Type 1 iodothyronine deiodinase (D1) is a crucial enzyme which converts the prohormone thyroxine (T4) into active tri-iodothyronine
 (T3). There has been strong evidence that the metabolism of thyroid hormones is disturbed in some neoplastic tissues such
 as thyroid, renal, and breast cancer. However, there are few available data about D1 enzyme activity in benign tumors such
 as hemangioma, which is the most common primary liver tumor. Hence this study aimed to determine the enzymatic activity of
 D1 in hemangiomas in relation to healthy liver tissue. Seven tumors and healthy control tissues were obtained from patients
 who had liver resection due to hemangioma. The activity was assessed by measurement of radioactive iodine released by deiodination
 catalyzed by D1. It...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3154068</comments>
            <pubDate>Mon, 04 Jan 2010 18:00:52 +0100</pubDate>
            <guid isPermaLink="false">3154068</guid>        </item>
        <item>
            <title>Cathelicidin LL-37: A Multitask Antimicrobial Peptide</title>
            <link>http://www.medworm.com/index.php?rid=3154069&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg1408572j6142605%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The antimicrobial peptide LL-37 is the only known member of the cathelicidin family of peptides expressed in humans. LL-37
 is a multifunctional host defense molecule essential for normal immune responses to infection and tissue injury. LL-37 peptide
 is a potent killer of different microorganisms with the ability to prevent immunostimulatory effects of bacterial wall molecules
 such as lipopolysaccharide and can therefore protect against lethal endotoxemia. Additional reported activities of LL-37 include
 chemoattractant function, inhibition of neutrophil apoptosis, and stimulation of angiogenesis, tissue regeneration, and cytokine
 release (e.g. IL-8). Cellular production of LL-37 is affected by multiple factors, including bacterial products, host cytokines,
 availabi...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3154069</comments>
            <pubDate>Mon, 04 Jan 2010 18:00:50 +0100</pubDate>
            <guid isPermaLink="false">3154069</guid>        </item>
        <item>
            <title>The Role of Heparanase in Diseases of the Glomeruli</title>
            <link>http://www.medworm.com/index.php?rid=3154070&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F88pm03667k50h160%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The glomerular basement membrane (GBM) is a kind of net that remains in a state of dynamic equilibrium. Heparan sulfate proteoglycans
 (HSPGs) are among its most important components. There are much data indicating the significance of these proteoglycans in
 protecting proteins such as albumins from penetrating to the urine, although some new data indicate that loss of proteoglycans
 does not always lead to proteinuria. Heparanase is an enzyme which cleaves β 1,4 d-glucuronic bonds in sugar groups of HSPGs. Thus it is supposed that heparanase may have an important role in the pathogenesis
 of proteinuria. Increased heparanase expression and activity in the course of many glomerular diseases was observed. The most
 widely documented is the significance of heparanase in ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3154070</comments>
            <pubDate>Mon, 04 Jan 2010 18:00:49 +0100</pubDate>
            <guid isPermaLink="false">3154070</guid>        </item>
        <item>
            <title>Cellular glucose transport and glucotransporter 4 expression as a therapeutic target: clinical and experimental studies</title>
            <link>http://www.medworm.com/index.php?rid=2960211&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F85175h65v368385p%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The three-month therapy with sulfonylurea resulted in a significant increase in CGT in all types of culture tests. This sulfonylurea-related
 improvement in CGT was associated with a near normalization of GLUT4 expression in the cells.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0052-7Authors
		Anna Czech, Warsaw Medical University (Brodnowski Hospital) Chair and Department of Internal Medicine, and Diabetology, Second Medical Faculty Warsaw PolandPaweł Piątkiewicz, Warsaw Medical University (Brodnowski Hospital) Chair and Department of Internal Medicine, and Diabetology, Second Medical Faculty Warsaw PolandJan Tatoń, Warsaw Medical University (Brodnowski Hospital) Chair and Department of Internal Medicine, and Diabetology, S...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2960211</comments>
            <pubDate>Tue, 03 Nov 2009 10:09:38 +0100</pubDate>
            <guid isPermaLink="false">2960211</guid>        </item>
        <item>
            <title>Resident peritoneal macrophages and mast cells are important cellular sites of COX-1 and COX-2 activity during acute peritoneal inflammation</title>
            <link>http://www.medworm.com/index.php?rid=2960212&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyu75u73406168780%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This study documents that both COX isoforms participate in all stages of acute inflammation and that tissue-resident leukocytes,
 especially macrophages, are important sites of COX-1/COX-2 expression and prostaglandin synthesis.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0053-6Authors
		Elzbieta Kolaczkowska, Jagiellonian University Department of Evolutionary Immunobiology, Institute of Zoology Kraków PolandAnna Goldys, Jagiellonian University Department of Evolutionary Immunobiology, Institute of Zoology Kraków PolandElzbieta Kozakiewicz, Jagiellonian University Department of Evolutionary Immunobiology, Institute of Zoology Kraków PolandMonika Lelito, Jagiellonian University Department of Evolutionary Immunobiology, Institu...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2960212</comments>
            <pubDate>Tue, 03 Nov 2009 10:09:28 +0100</pubDate>
            <guid isPermaLink="false">2960212</guid>        </item>
        <item>
            <title>Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection</title>
            <link>http://www.medworm.com/index.php?rid=2944752&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1p49667h663hq620%2F</link>
            <description>We present here a summary of the current approaches to validate new diagnostics
 based on the detection of immunological biomarkers of TB infection.
 
	Content Type Journal ArticleCategory ReviewDOI 10.1007/s00005-009-0050-9Authors
		Giovanni Ferrara, University of Perugia Section of Respiratory Disease, Department of Internal Medicine, St. Maria Hospital Via T. Di Joannuccio 1 05100 Terni ItalyMonica Losi, University of Modena and Reggio Emilia Center for Rare Lung Diseases Modena ItalyLeonardo M. Fabbri, University of Modena and Reggio Emilia Sections of Respiratory Diseases, Department of Oncology and Hematology Modena ItalyGiovanni B. Migliori, WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute Tradate ItalyLuca Richeldi, University of...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2944752</comments>
            <pubDate>Wed, 28 Oct 2009 20:23:24 +0100</pubDate>
            <guid isPermaLink="false">2944752</guid>        </item>
        <item>
            <title>Cardiomyocyte death in doxorubicin-induced cardiotoxicity</title>
            <link>http://www.medworm.com/index.php?rid=2944751&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F94t64ttg60081512%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Doxorubicin (DOX) is one of the most widely used and successful antitumor drugs, but its cumulative and dose-dependent cardiac
 toxicity has been a major concern of oncologists in cancer therapeutic practice for decades. With the increasing population
 of cancer survivors, there is a growing need to develop preventive strategies and effective therapies against DOX-induced
 cardiotoxicity, in particular late-onset cardiomyopathy. Although intensive investigations on DOX-induced cardiotoxicity have
 continued for decades, the underlying mechanisms responsible for DOX-induced cardiotoxicity have not been completely elucidated.
 A rapidly expanding body of evidence supports the notion that cardiomyocyte death by apoptosis and necrosis is a primary mechanism
 of DOX-induced ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2944751</comments>
            <pubDate>Wed, 28 Oct 2009 20:23:24 +0100</pubDate>
            <guid isPermaLink="false">2944751</guid>        </item>
        <item>
            <title>Complement: coming full circle</title>
            <link>http://www.medworm.com/index.php?rid=2944753&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0571444760865127%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The complement system has long been known to be a major element of innate immunity. Traditionally, it was regarded as the
 first line of defense against invading pathogens, leading to opsonization and phagocytosis or the direct lysis of microbes.
 However, from the second half of the twentieth century on, it became clear that complement is also intimately involved in
 the induction and “fine tuning” of adaptive B- and T-cell responses as well as lineage commitment. This growing recognition
 of the complement system’s multifunctional role in immunity is consistent with the recent paradigm that complement is also
 necessary for the successful contraction of an adaptive immune response. This review aims at giving a condensed overview of
 complement’s rise from a si...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2944753</comments>
            <pubDate>Wed, 28 Oct 2009 20:23:22 +0100</pubDate>
            <guid isPermaLink="false">2944753</guid>        </item>
        <item>
            <title>CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro</title>
            <link>http://www.medworm.com/index.php?rid=2944754&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp16120wq2rq3342u%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Taken as a whole, such accelerated differentiation of CD40-activated B cells suggests that IVIg may participate in re-equilibration
 of the antibody repertoire by replacing pathological antibodies by de novo harmless antibodies.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0048-3Authors
		Sonia Néron, Recherche et développement, Héma-Québec, Ingénierie cellulaire 1070, avenue des Sciences-de-la-vie Québec Qc G1V 5C3 CanadaGilles Boire, Université de Sherbrookeet Centre hospitalier universitaire de Sherbrooke Service de rhumatologie, Faculté de médecine et des sciences de la santé Sherbrooke Québec CanadaNathalie Dussault, Recherche et développement, Héma-Québec, Ingénierie cellulaire 1070, avenue des Sciences-de-la...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2944754</comments>
            <pubDate>Wed, 28 Oct 2009 20:23:21 +0100</pubDate>
            <guid isPermaLink="false">2944754</guid>        </item>
        <item>
            <title>Recent advances in multivalent self adjuvanting glycolipopeptide vaccine strategies against breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=2944755&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff054830382508136%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Breast cancer (BrCa) is the second leading cause of cancer-related deaths for women worldwide. Evidence from both patients
 and mouse cancer models suggests that the simultaneous induction of BrCa-specific CD4+ T cells, CD8+ cytotoxic T cells, and antibodies is crucial for providing immune resistance. However, almost all current vaccines address
 only a single arm of the immune system, which may explain their lack of efficacy. We believe that the correct response to
 monovalent vaccines’ “failure” is to increase our knowledge about antitumor protective immunity and to develop a multivalent
 vaccine molecule that can simultaneously induce multiple arms of the immune system. We highlight here recent advances in anti-BrCa
 peptide-based vaccine strategies with an emp...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2944755</comments>
            <pubDate>Wed, 28 Oct 2009 20:23:19 +0100</pubDate>
            <guid isPermaLink="false">2944755</guid>        </item>
        <item>
            <title>Introduction</title>
            <link>http://www.medworm.com/index.php?rid=2877345&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F451x086x4l2w4210%2F</link>
            <description>Content Type Journal ArticleCategory Varia – ScientometricsDOI 10.1007/s00005-008-0048-8Authors
		Eugene Garfield, Thomson Scientific ISI Philadelphia PA USA
	

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-4917Print ISSN 0004-069X
	
		Journal Volume Volume 56
	
		Journal Issue Volume 56, Number 6 / December, 2008 (Source: Archivum Immunologiae et Therapiae Experimentalis)</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2877345</comments>
            <pubDate>Thu, 08 Oct 2009 10:16:42 +0100</pubDate>
            <guid isPermaLink="false">2877345</guid>        </item>
        <item>
            <title>IRF4 selectively controls cytokine gene expression in chronic intestinal inflammation</title>
            <link>http://www.medworm.com/index.php?rid=2717238&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff0tvg07q6w557426%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The authors previously showed that interferon regulatory factor (IRF)4 knockout mice are protected from experimental oxazolone
 and TNBS colitis. Here the effect of IRF4 on the expression of pro- and anti-inflammatory cytokines in TNBS colitis and long-term
 CD45RBhigh transfer colitis is examined. In TNBS colitis, no differences were found in interleukin (IL)-18 and tumor necrosis factor
 (TNF)-α expression between IRF4 knockout and wild-type mice. However, significant differences were detected in IL-6 and IL-17 production.
 Upon treatment with hyper-IL-6, IRF4–/– mice lost their protective properties towards TNBS application. Hyper-IL-6 application induced IL-6 mRNA, but not IL-17 mRNA
 expression, suggesting that IL-6 deficiency is not primarily responsible for ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2717238</comments>
            <pubDate>Wed, 19 Aug 2009 18:44:26 +0100</pubDate>
            <guid isPermaLink="false">2717238</guid>        </item>
        <item>
            <title>Growth inhibition of Staphylococcus aureus by chicken egg yolk antibodies</title>
            <link>http://www.medworm.com/index.php?rid=2717237&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp8x3502rq56437x7%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;These findings indicate that eggs from hens immunized with appropriate antigens are a potentially useful source of passive
 immunity.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0041-xAuthors
		Marco Cesar Cunegundes Guimarães, UFES Laboratory of Cellular and Molecular Biology of Human Cancer Vitória ES BrazilLívia Gomes Amaral, UFES Laboratory of Cellular and Molecular Biology of Human Cancer Vitória ES BrazilLetícia Batista Azevedo Rangel, UFES Laboratory of Cellular and Molecular Biology of Human Cancer Vitória ES BrazilIan Victor Silva, UFES Laboratory of Cellular and Molecular Biology of Human Cancer Vitória ES BrazilClaudia Gomes Fernandes Matta, UFES Laboratory of Cellular and Molecular Biology of Human Cancer Vitó...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2717237</comments>
            <pubDate>Wed, 19 Aug 2009 18:44:26 +0100</pubDate>
            <guid isPermaLink="false">2717237</guid>        </item>
        <item>
            <title>Fetal-cell microchimerism, lymphopoiesis, and autoimmunity</title>
            <link>http://www.medworm.com/index.php?rid=2731258&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fak871j1ku154n255%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;During all human and murine pregnancies, fetal cells enter the maternal circulation and tissues and may persist there for
 decades. The immune consequences of this phenomenon have been explored for many years as a potential origin of autoimmunity
 or protection from cancer in women after pregnancy. The leading hypothesis, suggesting that semi-allogenic fetal T cells may
 trigger a graft-versus-host type of disease, has been supported by several studies showing an increased frequency of fetal-cell
 microchimerism (FMc) in women affected with systemic sclerosis. However, a large proportion of healthy women or women affected
 with non-immune disorders also display fetal T cells, challenging the direct pathogenic role of such cells. In addition, recent
 evidence showing the...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2731258</comments>
            <pubDate>Tue, 18 Aug 2009 08:25:36 +0100</pubDate>
            <guid isPermaLink="false">2731258</guid>        </item>
        <item>
            <title>Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides</title>
            <link>http://www.medworm.com/index.php?rid=2717239&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2238uvt723p41388%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Regardless of the complement resistance of the P. mirabilis strains, the S1959, R110, and R45 LPSs fragmented C3 and induced C3c neo-antigen exposure. The use of complement-deficient
 human serum allows the conclusion that the Re-type P. mirabilis R45 LPS fragmented C3 by the antibody-independent classical pathway.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0043-8Authors
		Wiesław Kaca, Huddinge University Hospital, Karolinska Institute Division of Clinical Bacteriology Huddinge SwedenMichał Arabski, Jan Kochanowski University Department of Microbiology, Institute of Biology Świętokrzyska 15 25-406 Kielce PolandRafał Fudała, Jan Kochanowski University Department of Microbiology, Institute of Biology Świętokrzyska 15 25-4...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2717239</comments>
            <pubDate>Tue, 18 Aug 2009 08:25:35 +0100</pubDate>
            <guid isPermaLink="false">2717239</guid>        </item>
        <item>
            <title>Factors that deregulate the protective immune response in tuberculosis</title>
            <link>http://www.medworm.com/index.php?rid=2713622&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr7617015m0p67063%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Tuberculosis (TB) is a chronic infectious disease which essentially affects the lungs and produces profound abnormalities
 on the immune system. Although most people infected by the tubercle bacillus (90%) do not develop the disease during their
 lifetime, when there are alterations in the immune system, such as co-infection with HIV, malnutrition, or diabetes, the risk
 of developing active disease increases considerably. Interestingly, during the course of active disease, even in the absence
 of immunosuppressive conditions, there is a profound and prolonged suppression of Mycobacterium tuberculosis-specific protective immune responses. Several immune factors can contribute to downregulate the protective immunity, permitting
 disease progression. In general, many of t...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2713622</comments>
            <pubDate>Tue, 18 Aug 2009 08:25:35 +0100</pubDate>
            <guid isPermaLink="false">2713622</guid>        </item>
        <item>
            <title>Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases</title>
            <link>http://www.medworm.com/index.php?rid=2713623&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl43rw83553323287%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The skin protects us from water loss and mechanical damage. The surface-exposed epidermis, a self-renewing stratified squamous
 epithelium composed of several layers of keratinocytes, is most important in the barrier defense against these challenges.
 Endogenous and exogenous proteases such as kallikreins, matriptase, caspases, cathepsins, and proteases derived from microorganisms
 are important in the desquamation process of the stratum corneum and are able to activate and inactivate defense molecules
 in human epidermis. Protease inhibitors such as like LEKTI, elafin, SLPI, SERPINs, and cystatins regulate their proteolytic
 activity and contribute to the integrity and protective barrier function of the skin. Changes in the proteolytic balance of
 the skin can result i...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2713623</comments>
            <pubDate>Mon, 17 Aug 2009 19:00:35 +0100</pubDate>
            <guid isPermaLink="false">2713623</guid>        </item>
        <item>
            <title>Immunopathogenesis of bronchial asthma</title>
            <link>http://www.medworm.com/index.php?rid=2713624&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc9h447l2533t8735%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Bronchial asthma is a common immune-mediated disorder characterized by reversible airway inflammation, mucus production, and
 variable airflow obstruction with airway hyperresponsiveness. Allergen exposure results in the activation of numerous cells
 of the immune system, of which dendritic cells (DCs) and Th2 lymphocytes are of paramount importance. Although the epithelium
 was initially considered to function solely as a physical barrier, it is now evident that it plays a central role in the Th2-cell
 sensitization process due to its ability to activate DCs. Cytokines are inevitable factors in driving immune responses. To
 the list of numerous cytokines already known to be involved in the regulation of allergic reactions, new cytokines were added,
 such as TSLP, IL-25...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2713624</comments>
            <pubDate>Mon, 17 Aug 2009 19:00:34 +0100</pubDate>
            <guid isPermaLink="false">2713624</guid>        </item>
        <item>
            <title>Fc receptor-targeted mucosal vaccination as a novel strategy for the generation of enhanced immunity against mucosal and non-mucosal pathogens</title>
            <link>http://www.medworm.com/index.php?rid=2713625&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu443hm5973672510%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Numerous studies have demonstrated that targeting immunogens to Fcγ receptors (FcγR) on antigen (Ag)-presenting cells (APC)
 can enhance humoral and cellular immunity in vitro and in vivo. FcγR are classified based on their molecular weight, IgG-Fc binding affinities, IgG subclass binding specificity, and cellular
 distribution and they consist of activating and inhibitory receptors. However, despite the potential advantages of targeting
 Ag to FcR at mucosal sites, very little is known regarding the role of FcR in mucosal immunity or the efficacy of FcR-targeted
 mucosal vaccines. In addition, recent work has suggested that FcRn is present in the lungs of adult mice and humans and can
 transport FcRn-targeted Ag to FcγR-bearing APC within mucosal lymphoid tissue. I...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2713625</comments>
            <pubDate>Mon, 17 Aug 2009 19:00:31 +0100</pubDate>
            <guid isPermaLink="false">2713625</guid>        </item>
        <item>
            <title>Interleukin 7 receptor α as a potential therapeutic target in transplantation</title>
            <link>http://www.medworm.com/index.php?rid=2592285&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl3385l1v0568286l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Drugs targeting memory lymphocytes may allow for a better control of rejection in transplantation, particularly in immunized
 patients. In this article the rationale of targeting interleukin 7 receptor a (IL-7Rα), a molecule expressed by both memory
 and naive T cells, is reviewed in the context of transplantation. Whereas naive T cells are partly responsible for acute rejection
 and are targeted by current immunosuppressive drugs that block costimulatory signals (cyclosporine A, anti-CD3 antibody, anti-CD52
 antibody, anti-thymocyte globulin, etc.), memory T cells are resistant to costimulation blockade. As such, memory cells are
 an obstacle to experimental tolerance induction and may be involved in chronic rejection. There is thus much scientific interest
 in develo...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2592285</comments>
            <pubDate>Thu, 09 Jul 2009 12:24:37 +0100</pubDate>
            <guid isPermaLink="false">2592285</guid>        </item>
        <item>
            <title>Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas</title>
            <link>http://www.medworm.com/index.php?rid=2589293&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Frh73312007642x11%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The weak MT expression and lack of p53 protein expression in pancreatic SCAs confirms the lack of local invasive potential
 of the neoplastic lesion. Increased expressions of MT and p53 were observed in the less differentiated tumors. Thus the expression
 of MT may be a potential prognostic marker for tumors.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0033-xAuthors
		Mariola Śliwińska-Mossoń, Wrocław Medical University Department of Biomedical and Environmental Analyses Grunwaldzka 2 50-355 Wrocław PolandHalina Milnerowicz, Wrocław Medical University Department of Biomedical and Environmental Analyses Grunwaldzka 2 50-355 Wrocław PolandJerzy Rabczyński, Wrocław Medical University Department of Pathological Anatomy Wroc...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589293</comments>
            <pubDate>Mon, 06 Jul 2009 20:24:11 +0100</pubDate>
            <guid isPermaLink="false">2589293</guid>        </item>
        <item>
            <title>Serological characterization of the core region of lipopolysaccharides of rough Proteus sp. strains</title>
            <link>http://www.medworm.com/index.php?rid=2589292&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr0506m144g623326%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Comparing the results of the serological studies with the known chemical structures of the core regions of the LPSs used enabled
 the identification of a few core oligosaccharide fragments probably involved in the observed cross-reactions. All were located
 in the most distal part of LPS core region, which made them more easily recognized by specific antibodies.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0034-9Authors
		Agata Palusiak, University of Łódź Department of General Microbiology, Institute of Microbiology, Biotechnology and Immunology Banacha 12/16 90-237 Łódź PolandZygmunt Sidorczyk, University of Łódź Department of General Microbiology, Institute of Microbiology, Biotechnology and Immunology Banacha 12/16 9...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589292</comments>
            <pubDate>Mon, 06 Jul 2009 20:24:11 +0100</pubDate>
            <guid isPermaLink="false">2589292</guid>        </item>
        <item>
            <title>Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=2589294&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1202405431827068%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Thus our results demonstrate that both IBD and CRC are linked with an intensified production of a wide array of monocyte/macrophage
 pro-inflammatory cytokines which is not accompanied by elevated levels of circulating IL-10, except for its insufficiently
 inhibitory elevation in UC patients.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0031-zAuthors
		Andrzej Szkaradkiewicz, University of Medical Sciences Department of Medical Microbiology Wieniawskiego 3 61-712 Poznań PolandRyszard Marciniak, University of Medical Sciences Department of General, Gastroenterological, and Endocrinological Surgery Poznań PolandIzabela Chudzicka-Strugała, University of Medical Sciences Department of Medical Microbiology Wieniawskiego 3 61-712 Po...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589294</comments>
            <pubDate>Mon, 06 Jul 2009 20:24:08 +0100</pubDate>
            <guid isPermaLink="false">2589294</guid>        </item>
        <item>
            <title>Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases</title>
            <link>http://www.medworm.com/index.php?rid=2589295&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F873858570u631j03%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Statins are inhibitors of the enzyme 3-hydroxy-3methylglutaryl coenzyme A (HMG-CoA) and they are the most effective agents
 for lowering cholesterol in clinical practice for the treatment of cardiovascular diseases. However, it has become clear that
 statins also have pleiotropic immunomodulatory effects in addition to their lipid-lowering properties. As a result, much attention
 has been focused on their potential as therapeutic agents for the treatment of inflammatory autoimmune diseases. In this review
 the effect of statins on the expression and function of a variety of immune-relevant molecules will be discussed alongside
 the underlying mechanisms that contribute to the immunomodulatory effects of statins.
 
	Content Type Journal ArticleCategory ReviewDOI 10.1007/...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589295</comments>
            <pubDate>Mon, 06 Jul 2009 20:24:07 +0100</pubDate>
            <guid isPermaLink="false">2589295</guid>        </item>
        <item>
            <title>Platelet influence on T- and B-cell responses</title>
            <link>http://www.medworm.com/index.php?rid=2589296&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0389405303487872%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Understanding the adaptive immune response is an area of research critically important in medicine. Several positive regulators
 of B- and T-cell activation exist to eliminate pathogens, in which CD40 ligand (CD154) plays a fundamental role. It is well
 documented that CD154 expressed by CD4 T helper cells can be critical in the proper activation of dendritic cells for the
 productive stimulation of CD8 T cells and is required for proper T-dependent B-cell immunity. However, platelets are an abundant
 and systemic source of CD154. While classically known to be important for hemostasis and inflammation, several lines of evidence
 suggest that platelet-derived ligands can modulate the adaptive immune compartment.
 
	Content Type Journal ArticleCategory ReviewDOI 10.1007/s...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589296</comments>
            <pubDate>Mon, 06 Jul 2009 20:24:04 +0100</pubDate>
            <guid isPermaLink="false">2589296</guid>        </item>
        <item>
            <title>Innate immunity: a key player in the mobilization of hematopoietic stem/progenitor cells</title>
            <link>http://www.medworm.com/index.php?rid=2589297&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy35x7162732171t3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The mobilization of hematopoietic stem/progenitor cells (HSPCs) from bone marrow into peripheral blood (PB) is still not fully
 understood. Different chemokines, cytokines, growth factors, and neurotransmitters have been described that facilitate this
 process. However, mounting evidence suggests that mobilization of HSPCs is a part of the immune response and is mediated by
 innate immunity. We discuss evidence showing that complement system cleavage fragments play a crucial role in both the retention
 and mobilization of HSPCs by modulating their responsiveness to stromal-derived growth factor-1 (SDF-1) gradient (by C3-derived
 anaphylatoxins) and by modulating the release of granulocytes into PB that subsequently facilitate the egress of HSPCs (by
 C5-derived anaphyla...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589297</comments>
            <pubDate>Mon, 06 Jul 2009 20:24:03 +0100</pubDate>
            <guid isPermaLink="false">2589297</guid>        </item>
        <item>
            <title>Pathogenicity of the family Legionellaceae</title>
            <link>http://www.medworm.com/index.php?rid=2589298&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw57076g2w1651055%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The Legionellae are Gram-negative bacteria able to survive and replicate in a wide range of protozoan hosts in natural environments, but
 they also occur in man-made aquatic systems, which are the major source of infection. After transmission to humans via aerosols,
 Legionella spp. can cause pneumonia (Legionnaires’ disease) or influenza-like respiratory infections (Pontiac fever). In children, Legionnaires’
 disease is uncommon and is mainly diagnosed in children with immunosuppression. The clinical picture of Legionella pneumonia does not allow differentiation from pneumonia caused by others pathogens. The key to diagnosis is performing appropriate
 microbiological testing. The clinical presentation and the natural course of Legionnaires’ disease in children ar...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589298</comments>
            <pubDate>Mon, 06 Jul 2009 20:01:41 +0100</pubDate>
            <guid isPermaLink="false">2589298</guid>        </item>
        <item>
            <title>Role of ocular pigment epithelial cells in immune privilege</title>
            <link>http://www.medworm.com/index.php?rid=2563785&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F22x515574778m574%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The ocular microenvironment is both immunosuppressive and anti-inflammatory in nature. Pigment epithelial (PE) cells isolated
 from the eye possess the ability to suppress the T cell receptor-dependent activation of T cells and the induction of regulatory
 T cells in vitro. This property is dependent on the cells’ capacity to produce cell-surface and soluble inhibitory molecules, for example
 CD86 (B7-2), transforming growth factor (TGF)-β, thrombospondin-1, programmed cell death 1 ligand 1 (PD-L1/B7-H1), and cytotoxic
 T lymphocyte-associated antigen 2α. Cultured ocular PE cells from the iris, ciliary body, and retina can individually suppress
 T-cell activation via mechanisms that partially overlap. Moreover, PE-derived regulatory T cells acquire functions that pl...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2563785</comments>
            <pubDate>Wed, 01 Jul 2009 06:18:43 +0100</pubDate>
            <guid isPermaLink="false">2563785</guid>        </item>
        <item>
            <title>Evaluation of lectin pathway activity and mannan-binding lectin levels in the course of pregnancy complicated by diabetes type 1, based on the genetic background</title>
            <link>http://www.medworm.com/index.php?rid=2474591&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F96t25206370p0304%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Diabetes, an autoimmune disease, is a serious complication of pregnancy. Therefore, determination of MBL status might be beneficial
 in identifying type 1 diabetic patients who are at increased risk of developing both vascular complications and poor pregnancy
 outcomes.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0029-6Authors
		Magdalena Pertyńska−Marczewska, Research Institute Polish Mother’s Memorial Hospital Department of Fetal-Maternal Medicine and Gynecology Łódź PolandMaciej Cedzyński, Polish Academy of Sciences Laboratory of Immunobiology of Infections, Institute of Medical Biology Łódź PolandAnna Świerzko, Polish Academy of Sciences Laboratory of Immunobiology of Infections, Institute of Medical Biology Ł...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2474591</comments>
            <pubDate>Thu, 11 Jun 2009 14:11:10 +0100</pubDate>
            <guid isPermaLink="false">2474591</guid>        </item>
        <item>
            <title>Dual use of biological research and the role of the scientific unions</title>
            <link>http://www.medworm.com/index.php?rid=2458692&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9r667l0210802708%2F</link>
            <description>Content Type Journal ArticleCategory VariaDOI 10.1007/s00005-009-0028-7Authors
		Angelo Azzi, JM USDA-HNRCA at Tufts University Vascular Biology Laboratory Office 622, 711 Washington St. Boston MA 02111 USA
	

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-4917Print ISSN 0004-069X (Source: Archivum Immunologiae et Therapiae Experimentalis)</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2458692</comments>
            <pubDate>Thu, 04 Jun 2009 11:19:44 +0100</pubDate>
            <guid isPermaLink="false">2458692</guid>        </item>
        <item>
            <title>Detection of a CD4+CD8−CD3− cell subpopulation during the differentiation of cord blood CD34+ cells into T cells in vitro</title>
            <link>http://www.medworm.com/index.php?rid=2448247&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd10v040t05133381%2F</link>
            <description>Conclusions:&amp;nbsp;&amp;nbsp;We showed that CD4+CD8−CD3− cells can be derived from highly purified CD34+ cells on TSCs during T-cell lymphopoiesis in vitro.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0022-0Authors
		Jian Gang Jin, Bei Tai Ping Lu Hospital Hematopoietic Stem Cell Transplant Center Bei Jing P.R.China 100039Bao Jun Bai, Bei Tai Ping Lu Hospital Hematopoietic Stem Cell Transplant Center Bei Jing P.R.China 100039Zhi Juan Yao, Bei Tai Ping Lu Hospital Hematopoietic Stem Cell Transplant Center Bei Jing P.R.China 100039Ren Na Wu, Bei Tai Ping Lu Hospital Hematopoietic Stem Cell Transplant Center Bei Jing P.R.China 100039Kai Feng, Bei Tai Ping Lu Hospital Hematopoietic Stem Cell Transplant Center Bei Jing P.R.China 100039Jiang Wei Hu, Bei Tai ...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448247</comments>
            <pubDate>Fri, 29 May 2009 06:53:58 +0100</pubDate>
            <guid isPermaLink="false">2448247</guid>        </item>
        <item>
            <title>Clinical and research ethics as moral strangers</title>
            <link>http://www.medworm.com/index.php?rid=2448251&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk845p66450623308%2F</link>
            <description>This article takes issue with those who defend a brand of clinical research ethics that tends to substitute the ethics of
 clinical care of patients being recruited as trial subjects. The distinction between therapeutic and non-therapeutic studies
 is being disregarded by arguing that research is concerned with the pursuit of knowledge rather than with the medical benefits
 for patients. Non-competent patients may therefore be recruited for studies that will offer them no medical benefits in spite
 of involving them in the inherent risks of any biomedical trial. Supported by the World Medical Association, clinicians tend
 to shun the use of placebos in randomized trials, because of the therapeutic void created in the control group. Nevertheless,
 investigators continue to consider that sci...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448251</comments>
            <pubDate>Fri, 29 May 2009 06:53:57 +0100</pubDate>
            <guid isPermaLink="false">2448251</guid>        </item>
        <item>
            <title>The expressions of intrinsic and extrinsic apoptotic pathway proteins in neutrophils of oral cavity cancer patients: a preliminary study</title>
            <link>http://www.medworm.com/index.php?rid=2448250&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk28641m02p000460%2F</link>
            <description>Conclusion:&amp;nbsp;&amp;nbsp;The acceleration of the apoptosis of PMNs of oral cavity cancer patients before treatment is dependent on both the intrinsic
 and extrinsic pathways.
 
 
 
	Content Type Journal ArticleCategory Short CommunicationDOI 10.1007/s00005-009-0023-zAuthors
		Ewa Jabłońska, Medical University of Białystok Department of Immunology Waszyngtona 15 A 15-274 Białystok PolandMarzena Garley, Medical University of Białystok Department of Immunology Waszyngtona 15 A 15-274 Białystok PolandJakub Jabłoński, Medical University of Białystok Department of Toxicology Białystok Poland
	

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-4917Print ISSN 0004-069X (Source: Archivum Immunologiae et Therapiae Experimentalis)</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448250</comments>
            <pubDate>Fri, 29 May 2009 06:53:57 +0100</pubDate>
            <guid isPermaLink="false">2448250</guid>        </item>
        <item>
            <title>Increased salivary level of 8-hydroxydeoxyguanosine is a marker of premature oxidative mitochondrial DNA damage in gingival tissue of patients with periodontitis</title>
            <link>http://www.medworm.com/index.php?rid=2448249&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcx3625001n2xu637%2F</link>
            <description>Conclusion:&amp;nbsp;&amp;nbsp;Increased oxidative stress may lead to premature oxidative DNA damage in the gingival tissue of periodontitis patients and
 the salivary 8-OHdG level may signify premature oxidative mtDNA damage in diseased gingival tissue.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0026-9Authors
		Cenk Fatih Çanakçi, Ataturk University Department of Periodontology, Faculty of Dentistry Erzurum TurkeyVarol Çanakçi, Ataturk University Department of Periodontology, Faculty of Dentistry Erzurum TurkeyAbdulgani Tatar, Ataturk University Department of Genetics, Faculty of Medicine Erzurum TurkeyAbubekir Eltas, Ataturk University Department of Periodontology, Faculty of Dentistry Erzurum TurkeyUfuk Sezer, Karadeniz Technical University Department...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448249</comments>
            <pubDate>Fri, 29 May 2009 06:53:57 +0100</pubDate>
            <guid isPermaLink="false">2448249</guid>        </item>
        <item>
            <title>Expanding and converting regulatory T cells: a horizon for immunotherapy</title>
            <link>http://www.medworm.com/index.php?rid=2448252&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb321667t5r728465%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The human immune system is a myriad of diverse cellular populations, each contributing to maintaining an effective and optimal
 immune response against infectious agents. It is important to maintain a “self-check” in the immune system so that responses
 do not go haywire, leading to the development of autoimmune diseases. Regulatory/suppressor T (Treg) cells are a specialized
 subpopulation of T cells that suppress the activation, expansion, and function of other T cells, thereby maintaining homeostasis
 through a fine balance between reactivity to foreign and self antigens. Tregs are characterized by surface expression of interleukin
 (IL)-2 receptor α chain (CD25) and intracellular expression of forkhead box protein P3 (FoxP3). There are at least two important
 f...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448252</comments>
            <pubDate>Fri, 29 May 2009 06:53:56 +0100</pubDate>
            <guid isPermaLink="false">2448252</guid>        </item>
        <item>
            <title>Dendritic cell-based cancer immunotherapies</title>
            <link>http://www.medworm.com/index.php?rid=2448253&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj81355l516330458%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Because of their unique role in linking the innate and adaptive immune systems, dendritic cells (DCs) have been a logical
 focus for novel immunotherapies. However, strategies employing active immunization with ex vivo generated and antigen–pulsed DCs have shown limited efficacy in clinical trials. These past approaches did not take into
 account the complex interactions between cells of the innate immune system and DCs during DC maturation, antigen processing,
 and presentation to naïve T cells. By better understanding the natural sequence of events occurring in vivo during an effective immune response, we can tailor antitumor immunotherapeutic strategies to augment aspects of this response
 from the activation of innate immune cells to antigen uptake and DC maturat...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448253</comments>
            <pubDate>Fri, 29 May 2009 06:53:55 +0100</pubDate>
            <guid isPermaLink="false">2448253</guid>        </item>
        <item>
            <title>The role of IL-1 in the pathogenesis of heart disease</title>
            <link>http://www.medworm.com/index.php?rid=2448254&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa68wg0m662112817%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Interleukin (IL)-1 consists of two distinct ligands, IL-1α and IL-1β, with indistinguishable biological activities that signal
 through the IL-1 type I receptor (IL-1RI). A naturally occurring IL-1 receptor antagonist (IL-1Ra) binds to IL-1RI without
 initiating signal transduction and prevents IL-1 signaling, competitively inhibiting IL-1-mediated responses. Emerging evidence
 suggests that the balance between IL-1 agonists and antagonists plays an essential role in a variety of cardiovascular conditions.
 IL-1 may play a role in atherothrombotic disease by promoting the formation of atheromatous lesions, enhancing vascular inflammation,
 and triggering plaque destabilization. Following myocardial infarction, IL-1 critically regulates the inflammatory response
 and i...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448254</comments>
            <pubDate>Fri, 29 May 2009 06:53:54 +0100</pubDate>
            <guid isPermaLink="false">2448254</guid>        </item>
        <item>
            <title>Role of ubiquitin ligases in neural stem and progenitor cells</title>
            <link>http://www.medworm.com/index.php?rid=2448255&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F95r782123410v063%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ubiquitin ligases are central components of the ubiquitin-proteasome system (UPS), the major machinery for regulated proteolysis
 in eukaryotic cells. Proteins essential for regulating development, differentiation, proliferation, cell cycling, apoptosis,
 gene transcription, and signal transduction undergo posttranslational processing via selection by ubiquitin ligases and subsequent
 controlled proteolysis by the 26S proteasome, the proteolytic unit of the UPS. Neural stem cells (NSCs) are self-renewing
 multipotent cells of the embryonic and adult mammalian central nervous system. In the last few years, NSCs have generated
 considerable interest because of their potential to repair neurological damage in preclinical models of stroke, spinal cord
 injury, and neurodege...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2448255</comments>
            <pubDate>Fri, 29 May 2009 06:53:53 +0100</pubDate>
            <guid isPermaLink="false">2448255</guid>        </item>
        <item>
            <title>TNF-α and sICAM-1 in intracranial aneurismal rupture</title>
            <link>http://www.medworm.com/index.php?rid=2303778&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh5252tu8864588r1%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This study demonstrated the absence of a systemic TNF-α-mediated inflammatory response at the onset of subarachnoid hemorrhage.
 Early measurement of serum sICAM-1 levels offers a potential prognostic value in the assessment of patients’ outcome after
 brain aneurismal rupture.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0010-4Authors
		Anna Maria Witkowska, Medical University Department of Food Commodities Science and Technology Mieszka I4b 15-054 Białystok PolandMaria Halina Borawska, Medical University Department of Bromatology Białystok PolandKatarzyna Socha, Medical University Department of Bromatology Białystok PolandJan Kochanowicz, Medical University Department of Neurosurgery Białystok PolandZenon Mariak, Medical...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2303778</comments>
            <pubDate>Thu, 02 Apr 2009 05:59:08 +0100</pubDate>
            <guid isPermaLink="false">2303778</guid>        </item>
        <item>
            <title>Antigen-restricted γδ T-cell receptors?</title>
            <link>http://www.medworm.com/index.php?rid=2303780&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Frw202q8784335516%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;After more than two decades of investigation, the biological role of the γδ T-cell receptors (TCRs) remains elusive. In fact,
 a theory of ligand recognition is still lacking that accounts for their adaptable structure, their peripheral selection, and
 the observed responses of γδ T cells, which do not require immunization but only include cells sharing germline-encoded components
 of the TCR. Assuming that all γδ T cells recognize ligands by a common mechanism, we now propose that germline-encoded components
 of the γδ TCRs provide for the specific recognition of a select set of antigenic determinants (Ags) which appear on the cell
 surface in various molecular associations. Furthermore, we hypothesize that the adaptivity of the γδ TCRs serves to increase
 af...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2303780</comments>
            <pubDate>Tue, 31 Mar 2009 05:53:26 +0100</pubDate>
            <guid isPermaLink="false">2303780</guid>        </item>
        <item>
            <title>A reflection on open-access, citation counts, and the future of scientific publishing</title>
            <link>http://www.medworm.com/index.php?rid=2303781&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F18g25gj22hk43u72%2F</link>
            <description>Content Type Journal ArticleCategory VariaDOI 10.1007/s00005-009-0016-yAuthors
		Xavier Bosch, University of Barcelona Department of Internal Medicine, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Villarroel 170 08036 Barcelona Spain
	

	
		Journal Archivum Immunologiae et Therapiae ExperimentalisOnline ISSN 1661-4917Print ISSN 0004-069X (Source: Archivum Immunologiae et Therapiae Experimentalis)</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2303781</comments>
            <pubDate>Tue, 31 Mar 2009 05:53:24 +0100</pubDate>
            <guid isPermaLink="false">2303781</guid>        </item>
        <item>
            <title>On the fairness of using relative indicators for comparing citation performance in different disciplines</title>
            <link>http://www.medworm.com/index.php?rid=2303784&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy6vp7837017q4042%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Relative indicators are commonly used to remove biases due to different citation practices in various scientific fields. Here
 we extend our recent investigation on the viability of the use of relative indicators for comparing article impact in different
 disciplines. We consider citation distributions for papers published in 14 of the 172 disciplines categorized by the Journal
 Citation Reports. The distribution of the number of citations received by publications in a certain discipline divided by
 the average number for the discipline is a universal function. Based on it, we compute the relative number of citations needed
 to be among the q percent most-cited publications in a discipline. The effect of finite samples is also discussed. The average
 number of citations...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2303784</comments>
            <pubDate>Tue, 31 Mar 2009 05:53:23 +0100</pubDate>
            <guid isPermaLink="false">2303784</guid>        </item>
        <item>
            <title>NKT cells: from totipotency to regenerative medicine</title>
            <link>http://www.medworm.com/index.php?rid=2303783&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg0681mg67q0642g2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The recent discovery that natural killer T (NKT) cell nuclei are totipotent opens a novel avenue for further understanding
 NKT cell function in normal and diseased states. The progeny of a cloned mouse harboring the in-frame rearranged Vα14-Jα18
 T cell receptor in one allele showed a significant increase in NKT cell number compared with wild-type or littermate control
 mice that possessed a different TCR. Importantly, NKT cells from such progeny produced both interferon-γ and interleukin-4,
 a hallmark of NKT cells. In these progeny, NKT cell development appeared to be instructively, rather than permissively, determined.
 Using embryonic stem cells prepared via the somatic cell nuclear transfer of NKT nuclei, relatively mature NKT cells were
 induced under conditio...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2303783</comments>
            <pubDate>Tue, 31 Mar 2009 05:53:23 +0100</pubDate>
            <guid isPermaLink="false">2303783</guid>        </item>
        <item>
            <title>ECA-immunogenicity of Proteus mirabilis strains</title>
            <link>http://www.medworm.com/index.php?rid=2303788&amp;cid=s_33469_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7654357692815586%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;These results therefore suggest that, similar to E. coli, LPS with a full core is also required as the acceptor of ECA for P. mirabilis strains to produce ECA
 LPS
 . Since ECA
 PG
 is not immunogenic unless combined with some proteins, it is likely that ECA
 PG
 -protein complexes formed during the intravenous immunization with the Rc mutant strain R4/O28.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00005-009-0018-9Authors
		Katarzyna Anna Duda, University of Silesia Department of Microbiology, Faculty of Biology and Environment Protection Katowice PolandKatarzyna Teresa Duda, University of Silesia Department of Microbiology, Faculty of Biology and Environment Protection Katowice PolandAgnieszka Beczała, University of Silesia Department...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2303788</comments>
            <pubDate>Tue, 31 Mar 2009 05:53:22 +0100</pubDate>
            <guid isPermaLink="false">2303788</guid>        </item>
    </channel>
</rss>

